








The role of intestinal mononuclear phagocytes in 

















Submitted in partial fulfillment of the  
requirements for the degree of  
Doctor of Philosophy  






















































Casandra Maria Panea 








The role of intestinal mononuclear phagocytes in control of mucosal T 
cell homeostasis 
 
                                Casandra Maria Panea 
 
The intestine is constantly exposed to a wide variety of dietary antigens, 
commensal bacteria and pathogens, toward which it has evolved complex immune 
responses to protect the host. The intestinal immune system relies on innate immune 
cells, such as mononuclear phagocytes (MNPs), that include dendritic cells (DCs), 
monocytes (Mo) and macrophages (Mfs), to sense and respond to luminal and mucosal 
challenges. MNPs are essential players as they instruct adaptive immune cells, in 
particular T cells, to discriminate between innocuous and harmful antigens. Generation of 
different CD4 T cell responses to commensal and pathogenic bacteria is crucial for 
maintaining a healthy gut environment, but the associated cellular mechanisms are poorly 
understood. Lamina propria (LP) T helper 17 (Th17) cells participate in mucosal 
protection and are induced by epithelium-associated commensal segmented filamentous 
bacteria (SFB). Several reports suggest that the cytokine environment induced by gut 
bacteria is sufficient to drive LP Th17 cell differentiation. In this context, intestinal DCs 
are proposed to facilitate the conversion of naïve CD4 T cells to Th17 cells within gut-
draining lymph nodes. Whether such mechanisms control commensal-mediated Th17 cell 
differentiation has not been examined. In this work, I explore the mechanisms of 
induction of Th17 cells by SFB, with a particular focus on the role of antigen-presenting 
cells in this process. 
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   Initiation of CD4 T cell responses requires both major histocompatibility II 
(MHCII)-mediated antigen presentation and cytokine stimulation, which can be provided 
by the same or different subsets of intestinal MNPs. To test the requirement for either 
function in the induction of Th17 cells by SFB, we analyzed the role of SFB-induced 
cytokine environment in driving Th17 cell differentiation of non-SFB transgenic CD4 T 
cells. We find that although the cytokine environment is important, it is not sufficient to 
promote Th17 cell differentiation of activated CD4 T cells. In fact, we show that MHCII-
dependent antigen presentation of SFB antigens by intestinal MNPs is crucial for Th17 
cell induction. Expression of MHCII on CD11c+ cells was necessary and sufficient for 
SFB-induced Th17 cell differentiation. We also show that most SFB-induced Th17 cells 
respond to SFB antigens, which stressed that they carry T cell receptors that recognize 
SFB moieties. SFB primed and induced Th17 cells locally in the LP and Th17 cell 
induction occurred normally in mice lacking secondary lymphoid organs.  
Our results outline the complex role of MNPs in the regulation of intestinal Th17 
cell homeostasis, and we investigated the contribution of individual subsets to SFB-
specific Th17 cell differentiation. Although the role of DCs in initiating T cell responses 
is well appreciated, how Mfs contribute to the generation of CD4 T cell responses to 
intestinal microbes is unclear. To this end, I examined the role of mucosal DCs and Mfs 
in Th17 induction by SFB in vivo. Employing DC and Mf subset-specific depletion and 
gain-of-function mouse models, I show that Mfs, and not conventional CD103+ DCs, are 
essential for generation of SFB-specific Th17 responses. Thus, Mfs drive mucosal T cell 
responses to certain commensal bacteria.  
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I. Architecture of the gut 
 
The intestine functions as a port of entry for food antigens and clinically relevant 
pathogens and a harbor for trillions of commensal microbes. The functions of the 
intestine include digestion and absorption of nutrients, secretion of hormones, and 
mounting of appropriate immune responses to food antigens, as well as commensal and 
pathogenic microbes. The anatomical layers of the gut in conjunction with the varied 
immune and non-hematopoietic cell types support these complex functions1. Intestinal 
walls are divided into four main layers consisting of the mucosa, submucosa, muscularis 
propria and serosa2-4 (Figure 1-1A).  
The mucosa is the innermost layer and is composed of three layers: epithelium, 
lamina propria, and muscular mucosae. As the first layer of the mucosa, the epithelium 
faces the lumen and exhibits invaginations called crypts of Lieberkuhn and finger-like 
projections known as villi. The epithelium contains several types of epithelial cells with 
distinct functions. The most abundant cell type is the enterocytes, which are specialized 
in nutrient absorption. Goblet cells secrete mucins for generation of a stratified mucus 
layer5, while enteroendocrine cells secrete various gastrointestinal hormones6. Microfold 
(M) cells contribute to development of immune responses, as they sample and deliver 
antigens to gut-associated lymphoid tissue (GALT). Tuft cells initiate type 2 effector T 
cell (Th2) responses.7-9. The precise functions of another epithelial cell lineage, cup cells, 
2 
are still unknown10,11. The crypts of Lieberkuhn are home to intestinal stem cells and 
Paneth cells, an epithelial cell lineage that supports growth of stem cells and secretes 
antimicrobial peptides into the lumen12. Underneath the epithelium and protected from 
luminal contents and constant microbial aggressions is the second layer of the mucosa, 
the lamina propria13,14,15. Lamina propria (LP) is a loose connective tissue replete with 
immune cells active in tolerogenic and inflammatory responses. Associated with the 
mucosa are lymphoid aggregates such as Peyer’s patches (PP) and isolated lymphoid 
follicles (ILFs), known collectively as organized gut-associated lymphoid tissue (GALT). 
PPs are present in the small intestine and contain M cells, which allow passage of luminal 
antigens for sampling by antigen-presenting cells for induction of both immunoglobulin 
A (IgA) responses and effector T cell responses. ILFs are scattered throughout the small 
intestine and generated in response to microbial stimuli and control enteric flora through 
induction of IgA responses16.  
Underneath the LP is its supporting submucosa, which is outlined by smooth 
muscles that form the muscularis externa2. The muscularis externa consists of two layers 
of smooth muscles, longitudinal and circular, alternating with two layers of nerve 
supplies, myenteric plexus and deep muscular plexus, respectively2. The enteric nervous 
layers of the muscularis regulate gut peristalsis and tolerogenic immune responses 
through crosstalk with muscularis macrophages 17,18.  
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Figure. 1-1: Architecture of the small intestine.  
A. The small intestine is comprised of stratified layers of specialized tissue.  The 
small intestine can be subdivided into four major layers: mucosa, submucosa, muscularis 
externa, and serosa. The mucosa consists of the epithelium and the lamina propria. The 
epithelial sublayer, constantly replenished by stem cells residing in intestinal crypts, 
functions as a barrier for the underlying layers from the constant luminal aggressions.  
B. Overview of the immune cells of the small intestinal mucosa. Through production 
of stratified mucus layers, antimicrobial peptides, and immunoglobulins, the intestinal 
epithelial layer separates the immune cells of lamina propria from the contents of the 
lumen. Mononuclear phagocytes (MNPs), including CD64 Mf and the different types of 
LP DCs, have the capacity to sample the lumen for both oral and microbial antigens 
while maintaining the integrity of the epithelial barrier. ILCs integrate stimuli from either 
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IECs or LP MNPs and complement and strengthen the intestinal epithelial barrier. 
Various LP DC subsets prime T cells either in the GALT (i.e. PPs and ILFs) or the gut-
draining mesenteric lymph nodes to induce specific effector lineages. The majority of 
mucosal effector T cells are activated, regardless of their intraepithelial or lamina propria 
compartment, and they commit to their T helper cell fate in response to a specific 
cytokine milieu. Depending on the type of GALT, B cells differentiate into IgA-
producing plasma cells in a T cell- dependent (PPs) or T cell-independent (ILFs) manner, 
and the secretory IgA molecules are crucial for coating microbes. Abbreviations: IEC, 
intestinal epithelial cell; IEL, intraepithelial lymphocyte; ILC, innate lymphoid cell; PP, 
Peyer’s Patch; ILF, isolated lymphoid follicle; DC, dendritic cell; Mf, macrophage; IL, 
interleukin; RA, retinoic acid; TGF, transforming growth factor; IgA, immunoglobulin A; 
Th, effector T helper cell lineage; pTreg, peripherally-induced regulatory T cell.      
 
II. Intestinal mononuclear phagocyte system 
  
The intestine is constantly exposed to a wide variety of dietary antigens, 
commensal bacteria and pathogens, toward which it has evolved complex immune 
responses to protect the host. The intestinal immune system relies on innate immune 
cells, such as dendritic cells (DCs) and macrophages (Mfs) to sense and respond to 
luminal and mucosal challenges. MNPs are essential players as they instruct adaptive 
immune cells to discriminate between innocuous and harmful antigens. As a result, they 
promote tolerance to harmless dietary and commensal antigens and facilitate mounting of 
active immunity to pathogens. Both DCs and Mfs can sample antigen from the 
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environment, and DCs can migrate to the gut draining lymph nodes (mesenteric lymph 
nodes, MLNs), where they present antigens to naïve T cells for induction of appropriate 
effector T cell responses. Mfs are mostly resident in the lamina propria and perform local 
functions including engulfing and clearing pathogens, amplifying effector T cell 
responses and recruiting other immune cells for tissue repair and wound healing. While 
much is known about the functions of intestinal MNPs in induction of effector T cell 
responses to various pathogens, their role in commensal-driven T cell homeostasis is less 
clear. Elucidating the contribution of the different MNP subsets toward commensal-
mediated T cell responses will help uncover mechanisms of discrimination between 
harmless and harmful microbes. 
 
III. Intestinal MNP subsets  
 
Intestinal MNPs arise from a common BM progenitor, but intestinal DC subsets 
and Mfs follow distinct developmental pathways due to defined precursors (Figure 1-2). 
The common myeloid progenitors (CMP) in the BM have the potential to generate DCs, 
Mfs, granulocytes, neutrophils and eosinophils19. CMPs then differentiate into two 
lineages, macrophage/dendritic cell progenitors (MDPs) and granulocyte/macrophage 
progenitors (GMPs), where the MDP lineage generates only DCs and 
monocytes/macrophages20,21. MDPs are identified based on expression of chemokine 
receptor CX3CR1, growth factor receptors FLT3, M-CSFR, and stem cell factor, cKIT, 
while lacking expression of major histocompatibility complex II (MHCII), lymphoid, 
erythrocyte and NK lineage markers. MDPs give rise to two lineages, monocytes and 
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common DC progenitors (CDP)20. CDPs retain expression of CX3CR1, FLT3 and M-
CSFR but lose potential to differentiate into monocytes/macrophages. CDPs generate 
plasmacytoid DCs (pDCs) and pre-DCs22,23. Pre-DCs are committed to the conventional 
DC (cDC) lineage and express CD11c but are MHCII negative. In addition, expression of 
zinc finger transcription factor Zbtb46 identifies a subset that has lost pDC potential as 
early as the CDP lineage24. This finding underscores Zbtb46 as a marker of both cDC-
restricted progenitors and of differentiated cDC subsets. Pre-DCs exit the BM and 
circulate in blood to tissues, where they mature into cDC1 cells (CD8α+ in lymphoid 
organs) and cDC2 cells (CD11b+ or CD4+ in lymphoid organs) that undergo local 
proliferation24,25.  
Ly6chi monocytes retain expression of CX3CR1 and M-CSFR, gain expression of 
CD11b and the chemokine receptor CCR2, but lose expression of FLT3 and cKIT. BM 
Ly6chi monocytes have a short half-life and emigrate from the BM in response to 
chemokine ligand 2 (CCL2, also known as monocyte chemoattractant protein 1 (MCP1)) 
and CCL7 (also known as MCP3), which are ligands for CCR226,27. While MDPs and 
CDPs reside within the BM, pre-DCs and Ly6chi monocytes circulate in the blood and 
can extravasate into tissues to repopulate DC and Mf populations, respectively. 
Circulating Ly6chi monocytes give rise to Ly6clow monocytes, which mostly patrol blood 
vessels to ensure their integrity at steady state28,29. Ly6chi monocytes are constantly 
recruited to tissues such as intestine, skin and heart to replenish resident macrophages30-
32. In other tissues, macrophages originate from embryonic progenitors. Microglia 
develop exclusively from yolk sac-derived progenitors identified as erythro-myeloid 
progenitors33, EMPs. Most other tissue-resident macrophages originate from EMP-
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derived fetal liver macrophages and fetal liver monocytes, although the latter origin is 
still debated due to differences in fate mapping models and marker identification of 
progenitor populations34-38. A small contribution from adult HSC-derived circulating 
monocytes is seen with increase in age or in response to tissue-specific signals 32,35,39. 
Once the progenitors seed the tissue, they undergo local proliferation to maintain the 
resident macrophage niche throughout adulthood40-46. Similarly, during radiation-induced 
monocytopenia or inflammation, remaining resident macrophages expand via local 
proliferation47-50.  
Intestinal MNPs consist of several DC and Mf subsets, which are interspersed 
within the GALT, LP, muscularis externa and populate MLNs3,51,52 (Figure 1-1B). MNPs 
are identified based on expression of CD45, which marks all descendants of bone 
marrow-derived hematopoietic stem cells, and lack of lymphocyte, granulocyte and 
erythrocyte lineage markers53. Tissue MNPs express integrin CD11c and upregulate 
expression of major histocompatibility complex II (MHCII)54. LP and MLN DCs express 
high levels of both MHCII and CD11c, whereas LP Mfs and muscularis Mfs express 
intermediate and low levels of CD11c, respectively3,17. Within the intestine, LP and MLN 
DC subsets express conventional DC markers CD24 and CD26, and differential levels of 
integrins CD103 and CD11b. LP, muscularis and MLN macrophages lack CD103 but 
express CD11b, as well as CX3CR1, and the phagocytic receptor, FcγRI or CD64. 
Transcriptomic analyses revealed additional transcriptional factors and surface receptors 
that define these populations based on their origins, phenotypes and functions (Table 1-1) 
17,55-58. 
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Currently, it is unclear whether progenitors seed discrete segments and 
compartments of the gut and whether distinct precursors replenish the same MNP subset 
during homeostasis and inflammation. While some recent studies propose that precursors 
to lymphoid classical DC lineages are primed in the bone marrow57, it is not known 
whether the same imprinting occurs for peripheral DC and macrophage progenitors. In 
addition, confounding evidence around phenotypic markers used to describe the fate or 
function of specific subsets (i.e. CX3CR1 and F4/80 expression on macrophages versus 
DCs; MHCII, CD80 and CD86 positivity to describe functional antigen presenting cells) 
underscores the need to move from phenotypic to functional classification of MNPs. 
 
Table 1-1. Phenotype of intestinal MNPs. Intestinal MNPs can be classified as DCs or 
Mfs based on their origins, their transcription factor requirements and other surface 
receptors or ligands that instruct their development and function. MNP-mononuclear 
phagocytes; TF-transcription factors; SP-single positive; DP-double positive. References: 




Figure 1-2. Distinct ontogeny and phenotype of intestinal Mfs and DCs (Adapted 
from 62). In response to a CCL2 gradient, CCR2+Ly6chi blood monocytes enter the gut 
mucosa regularly and differentiate through a series of monocyte/macrophage 
intermediates into mature, tissue-resident intestinal Mfs. Intestinal Mfs express high 
levels of CD64, F4/80, and CX3CR1. Albeit some DCs express intermediate levels of 
F4/80 and CX3CR1, all intestinal DCs express high levels of CD24 and Zbtb46. 
Committed Flt3L-dependent progenitors enter the gut mucosa constitutively and 
reconstitute at least three different intestinal DC subsets. Both CD103-negative subsets 
are presumably GALT-derived, but the populations are heterogeneous and their exact 
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origins are unclear. Abbreviations: GALT, gut-associated lymphoid tissues; Mf, 
macrophage; cDC, classical dendritic cell; Flt3L, fms-like tyrosine kinase 3 ligand; 
Zbtb46, zinc finger and BTB domain containing 46; IEC, intestinal epithelial cell.       
 
A. Development of intestinal macrophages  
 
Macrophages are the most abundant MNPs in both SI and LI lamina propria63 
representing over 50% of the CD11c+MHCII+ cells at steady state64. Development of 
tissue-resident macrophages has been thoroughly investigated34-38.  
Embryonic progenitors seed the intestinal mucosa and proliferate in situ during 
the neonatal period but upon weaning, they are fully replaced by newly differentiated 
macrophages 65. These adult intestinal macrophages originate from circulating 
monocytes, which are recruited to the intestine through a CCL2-CCR2-dependent 
mechanism and differentiate locally in the lamina propria in response to bacterial signals 
65. In competitive CCR2-/-:WT bone-marrow chimeras, macrophages derive exclusively 
from CCR2-sufficient monocytes 30,66. However, monocytopenic CCR2-/- mice show 
similar proportions of intestinal macrophages as wildtype controls pointing to a role for 
CCR2-independent recruitment of circulating monocytes to the lamina propria, as has 
been described during bacterial infection26 (our observations and 66,67). CCR2-/- mice 
show similar maturation of intestinal macrophages and priming of CD4 T cells compared 
to wildtype controls at steady state 67, but CCR2-/- macrophages are functionally impaired 
and fail to license ILC3 cells to clear infection with C. rodentium 68.  
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Intestinal macrophage development occurs through a series of monocyte-
macrophage intermediates (described as “Mo-waterfall” 16), which is characterized by 
gradual downregulation of LY6C expression and upregulation of CX3CR1, MHCII, 
CD64, and CD11c expression leading to Ly6cnegCCR2low/negCX3CR1hi 
CD64hiMHCIIhiCD11cint/lowCD11b+ Mfs 30,36,52. A similar differentiation process has been 
noted for dermal monocyte-derived DCs 32. The “Mo-waterfall” is an attribute of recently 
extravasated monocytes because LY6C-expressing blood monocytes are exclusively 
Ly6chiCCR2hiCX3CR1intCD64lowMHCIInegCD11clow/negCD11b+ 30. Ly6chi blood 
monocytes generate Ly6cnegCX3CR1hiCCR2-CD11b+CD115+ blood monocytes by 19hrs 
upon exit from BM 28,36,52, however, adoptive transfers of Ly6cneg cells cannot replenish 
the lamina propria macrophage niche 52. Therefore, Ly6chi blood monocytes are the sole 
progenitors of lamina propria macrophages. Similar to other nonlymphoid tissues, lamina 
propria macrophages undergo clonal expansion from extravasated Ly6chi blood 
monocytes as competitive monocyte transfers lead to patchy reconstitutions of 
macrophages52. Lamina propria macrophage development from blood monocytes occurs 
under the control of macrophage-colony stimulating factor (M-CSF) 18,51,52,69,70 and does 
not rely on fms-like tyrosine kinase 3 ligand (Flt3L) 51,52. In addition to growth factors, 
commitment to and maintenance of the macrophage fate are driven by transcription 
factors, e.g. PU.1, AML-1 and MafB 71-73.  
MLN macrophages appear to develop directly from blood monocytes and do not 
require a lamina propria intermediate as numbers of MLN-resident macrophages are not 
reduced in CCR7-/- mice, in which migration of MNP subsets to MLN is impaired 30. In 
the case of PPs, both Ly6chi and Ly6clow/neg blood monocytes can replenish macrophages 
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but in distinct subcompartments, i.e. Ly6clow/neg blood monocytes can repopulate the 
subepithelial dome of PPs, but not the PP-associated villi 52. Muscularis Mfs are depleted 
similarly to mucosal macrophages by monocyte-macrophage ablation models, such as 
LysMΔCsf1rDTR (also known as MM-DTR) and anti-CSF1 monoclonal antibody, 
suggesting a similar developmental origin to lamina propria macrophages 70. While their 
dependency on Ly6chi blood monocytes has not been investigated directly, Seo et al 
suggest that CD115+CD11clowMHCII+CD11b+ muscularis macrophages are not depleted 
in DT-treated CCR2-DTR, which they attribute to a lack of contribution of circulating 
monocytes to this population68. However, these results may indicate a slower turnover 
rate of muscularis macrophages compared to mucosal macrophages since the DT-treated 
recipients were analyzed 72hrs after the first DT injection. Indeed, when we treat CCR2-
DTR mice with DT for longer periods of time, we could achieve complete depletion of 
both mucosal and muscularis macrophages 69.  
 
B. Development of intestinal DCs 
 
Intestinal LP DCs are short-lived and are constantly replenished from pre-
DCs51,52,55,74. The LP dendritic cell network can be divided into three main populations 
based on differential expression of CD103 and CD11b and developmental control by 
transcription and growth factors. An additional subset of CD103-CD11b- DCs has also 
been proposed, however, its origins are unclear as this subset is highly variable and may 
contain contaminating MNPs from MLNs62. All DC subsets are represented in different 
proportions throughout distinct segments of the small intestine (i.e. duodenum, jejunum, 
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and ileum), but whether their localization contributes to regional immune specialization 
remains to be determined64.  Future studies will have to address also whether DC 
progenitors home to distinct segments of the intestine to replenish local MNP 
populations.  
 
CD103+CD11b- dendritic cells (CD103 SP DCs) 
Similarly to CD8α conventional DCs, and other nonlymphoid tissue CD103+ 
DCs, LP CD103+CD11b- dendritic cells develop from Flt3L-dependent pre-DCs via the 
MDP-CDP axis and do not rely on GM-CSF or M-CSF 51,52,56,75,76.   
 CD103 SP DCs represent ~30% of total cDCs in the small intestine, ~75% of total 
cDCs in the colon, over 50% in PPs and migratory MLN DCs 51,64,77. Despite their large 
representation in the GALT, CD103 SP DCs are present in normal numbers in the LP of 
RORγt-/- mice, which lack GALT, suggesting that they do not require GALT for their 
differentiation and development 78. CD103 SP DC development is driven by the 
transcription factors ID2, IRF8, BATF3, and NFIL3 74,79-82, although ID2 expression is 
not restricted to CD103+ and CD8α cDCs 83 and NFIL3 also controls production of 
IL12p40 from macrophages84. Autoactivation of IRF8 is required for specification of an 
early clonogenic progenitor of CD8α DCs in the BM.  BATF3 maintains autoactivation 
of IRF8 in this progenitor and ensures final differentiation to CD8α cDCs. In the absence 
of BATF3, differentiation into CD8α DC fails due to decay of IRF8 autoactivation and all 
pre-DC progenitors generate CD4+ cDCs 85. This study complements an earlier finding 
that commitment to cDC1 (CD8α DCs) and cDC2 (CD4+ DCs) lineages occurs in the BM 
and not the periphery 57. Moreover, comparative transcriptional profiling of CD103 SP 
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DCs and CD103+CD11b+ DCs (DP DCs) revealed divergent programming in the 
specification of each lineage 58. For example, the transcriptional repressor BCL6 was 
enriched in CD103 SP DCs and CD103 SP DC development was severely impaired in 
BCL6-deficient mice. On the other hand, Blimp1 was preferentially expressed in DP DCs 
and DC-specific ablation of Blimp1 resulted in decreased levels of DP DCs and a reduced 
ratio of DP DCs to CD103 SP DCs 58.   
 
CD103+CD11b+ dendritic cells (double-positive, DP DCs)    
DP DCs represent over 60% of total cDCs in the small intestinal lamina propria, 
~5-10% of the total cDCs in PPs and colonic lamina propria and less than 50% of 
migratory MLN DCs 51,64,70,77. 
DP DCs resemble CD4+CD11b+ conventional DCs through their requirement for 
the growth factor Flt3L and transcription factors Irf2, Irf4 and Notch2 for their 
development and survival 56,61,86. As mentioned above, the transcriptional repressor 
Blimp1 also appears to control in a cell-intrinsic manner the development or maintenance 
of DP DCs 58. Based on competitive BM chimeras, DP DC development partially 
requires GM-CSF signaling to maintain normal numbers 51,52. In addition, lymphotoxin β 
receptor (LTβR) signaling promotes homeostatic expansion of DP DCs, similarly to its 
contribution towards splenic Notch2-dependent Esam+CD11b+ DCs 86,87. Signal 
regulatory protein alpha (SIRPα; CD172)-CD47 axis may also control the survival of DP 
DCs as SIRPα- and CD47-deficient mice have 50% reduction in DP DC levels in SI LP, 
LI LP and MLN 88. 
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DP DCs may be a heterogeneous population that includes some monocyte-derived 
cells as some expression of F4/80, and intermediate levels of CX3CR1 and CSF1R have 
been observed. Moreover, DP DCs are not completely deleted in Flt3L-/- mice and 
Zbtb46-DTR BM chimeras treated with DT for a short period of time 56,57,70,74,75. The 
heterogeneity of this population was proposed to resemble that of CD8+CD11b+ splenic 
DCs, which are subdivided into Notch2-dependent Esam+CD11b+ cells and Notch2-
independent Esam-CD11b+CX3CR1-GFPhi monocyte-like cells 56,86. In our work, we 
noticed that a small proportion of DP DCs express F4/80int, CX3CR1int and CCR2int 
(CD64 and CD115 are not expressed), but we also obtained complete ablation of the 
population in Zbtb46-DTR BM chimeras and no significant ablation in LysMΔCsf1rDTR or 
CCR2-DTR mice treated with DT for 7 days. Therefore, it is possible that the 
composition of this subset depends on environmental cues, such as inflammatory 
microbiota.  
It is currently unclear whether the two subsets of CD103 DCs develop from 
defined progenitors and whether they are clonally committed prior to entry into the 
intestinal lamina propria. In fact, recent findings suggest commitment occurs in the BM57. 
 
CD103− intestinal DCs (also, CD11b SP DCs) 
Most intestinal DCs express CD103 (discussed above), but a CD103− DC 
population has emerged in recent years. CD103− DCs express CD11b and were grouped 
initially with CD11b+ Mfs, but they express the DC-specific marker CD24 and lack 
expression of CD64, distinguishing them from CD64+ Mfs 56,61,64,66,69,70,77,78. CD11b SP 
DCs represent ~5-10% of total cDCs in small intestine, colon and GALT 56,61,66,77. 
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Development of CD11b SP DCs has yet to be fully understood because of the lack of 
known developmental transcription factors. CD11b SP DCs expand in response to Flt3L 
and are reduced in RORγt-/- mice suggesting that they are GALT-derived 61,66,78. IRF4 
deficiency impairs the development of CD103- migratory MLN DCs, suggesting a 
potential role for this transcription factor in the specification and migration to the lymph 
of a subset of CD103- SI LP DCs that expresses CCR2 61,66.  Earlier BrdU pulse-chase 
experiments revealed that CD11b SP DCs accumulate within MLNs at a faster pace than 
within SI LP and undergo local homeostatic proliferation suggesting distinct origin from 
blood precursors89. In contrast to CD64 Mfs, Ly6clowCD11b+CCR2neg cells, can replenish 
PP CD11b SP DCs within the subepithelial dome8. Transfers of Ly6chigh blood 
monocytes do not reconstitute CD11b SP DCs, demonstrating that these cells do not 
share developmental origin with intestinal macrophages. 
CD11b SP DCs express intermediate levels of CX3CR1 and are reduced, albeit 
not ablated, in mice treated with high doses of anti-CSF1R monoclonal antibody, as well 
as DT-treated LysMCsf1rDTR mice (70, and our own observations). Currently, the origin of 
this population is debated and they have been proposed to be a mix of conventional DCs, 
monocyte-derived cells and monocyte-macrophage intermediates 56.  
 
IV. Intestinal CD4 T cells 
 
The intestinal LP contains both innate and adaptive immune cells involved in 
acquiring, processing and translating food and microbial stimuli into information needed 
to maintain intestinal immune homeostasis. As mentioned above, intestinal MNP subsets 
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sample antigens from the environment and deliver it to mucosal sites where adaptive 
immune responses are initiated. Within these sites, T and B cells are primed and 
instructed to home to the LP, or disseminate systemically, to perform their effector 
functions. Beside LP, a unique subset of T cells resides in the epithelial layer. These T 
cells, called intra-epithelial lymphocytes (IELs) consist of 60% γδ TCRs and fewer αβ 
TCRs90,91. TCRγδ IELs are mostly CD8αα+, whereas TCRαβ IELs are either CD8αα+ or 
CD8αβ+. IELs are either natural or induced depending on they type of antigens they 
recognize and their mechanism of induction92. Natural IELs are activated in the thymus in 
presence of self-antigens, populate the gut early in life and maintain constant numbers 
over time. Induced IELs are conventional T cells, which encounter their non-self antigen 
in peripheral lymph nodes and subsequently migrate to the epithelium. Recent work has 
revealed that IRF8-dependent CD103+CD11b- DCs are responsible for development of 
CD8αβ and CD4+CD8αα+ IELs93. The majority of LP CD4 T and IELs present in 
conventional mice have effector/memory phenotype, which is explained by constant 
antigen exposure, however their specificities remain poorly characterized 94-97. Effector 
CD4 T cells dominate the intestine and GALT at steady state.  Effector CD4 T cells 
consist of diverse subsets with specific cytokine and chemokine profiles. They activate 
cytotoxic T cells, instruct MNPs to perform bactericidal functions, and promote B cell 
differentiation and antibody production. Th1, Th2 and Th17 cells promote immune 





A. Overview of effector CD4 T cell differentiation 
The first step of mucosal CD4 T cell activation involves MHCII-mediated 
presentation of antigens by innate immune cells. Engagement of the T cell receptor with 
cognate antigen-MHCII complex is then followed by crosslinking of costimulatory 
molecules from both the APC and the primed CD4 T cell. Cytokines derived from either 
the same APCs or other innate immune cells are crucial for initiating the transcriptional 
changes required for skewing the differentiation of activated CD4 T cells towards a 
specific lineage. Key cytokines produced by each lineage then play a role in maintenance 
of the lineage identity through positive feedback or auto-amplification loops as well as 
through cross-inhibition of other lineages. Nevertheless, mature effector CD4 T cells can 
de-differentiate in response to various signals, i.e. from Tregs to Th1798,99, from Th17 to 
Tregs100 and from Th17 to Th1101. Conversion of CD8 T cells into MHCI-restricted 
regulatory-like CD4 T cells in the colonic lamina propria has also been reported, 
underscoring the unique nature of the gut environment 102,103. 
 
B. Induction of intestinal CD4 T cell responses 
Organized secondary lymphoid tissues associate with each organ and are thought 
to be the sites where T cell responses are initiated (i.e. inductive sites). Naïve T cells 
encounter luminal antigen in the gut-draining MLN or GALT, which includes PPs and 
ILFs. Formation of any of these structures requires lymphotoxin-α1β2 (LTα)-LTβR 
interactions and RORγt. In addition, ILFs also depend on RANK and TNF-receptor I 
signaling for their development 104,105.  
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 Antigen-loaded DCs from the LP, but also PPs and ILFs, migrate to MLNs in a 
CCR7-dependent manner to prime and activate naïve T cells106,107. MLNs are the main 
induction sites for regulatory T cell (Tregs)-facilitated oral tolerance as mice lacking 
MLNs or mice unable to deliver antigens to MLNs fail to induce tolerance to orally 
administered soluble antigens107-109. Most of migratory MLN DCs can be identified as 
MHCIIhiCD11c+ cells compared to resident MLN DCs, which are MHCIIint. Homing of 
activated T cells to the gut mucosa relies on expression of homing receptor CCR9 and 
integrin α4β7, which are induced on T cells while still present in the MLNs by CD103 SP 
DCs 77,89,93. The ligand for integrin α4β7 is mucosal addressin cell-adhesion molecule 
(MadCAM)-1110, which is expressed by endothelial cells of mucosal tissues, whereas the 
ligand for CCR9 is the chemokine CCL25111, which is released by small intestinal 
epithelial cells. CCR9-dependent homing is a characteristic of SI LP, as G protein-
coupled receptor (GPR) 15 controls T cell homing to the colonic LP112.  
In the absence of DP DCs 61,113 both induction of gut tropism and peripherally-
induced Tregs (pTregs) are unaffected reinforcing a clear division of labor between 
CD103 SP DCs and DP DCs. The ability of CD103 SP DCs to induce gut tropism on 
activated T cells relies on their ability to synthesize the vitamin A metabolite, retinoic 
acid, whose production is enhanced by intrinsic IL-4 signaling, TLR2 ligation and 
GMCSF signaling 114-117. Both in vitro and ex vivo assays blocking retinoic acid receptor 
signaling abolishes the ability of CD103 SP DCs to convert activated T cells into pTregs, 
highlighting the essential role RA plays in conjunction with TGFβ for induction of 
FoxP3+ pTregs 118-121. In fact, CD103+ DCs can activate latent TGFβ through their 
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expression of αvβ8, which endows them with the specialized ability to induce pTregs in 
the MLNs 122,123.  
In addition to the RA-producing CD103 SP DCs, MLN-resident stromal cells 
produce high levels of RA and can both imprint activated T cells, specifically with α4β7, 
and enhance the gut-tropism function of migratory CD103 SP DCs 124. This is a feature of 
MLN resident stromal cells and of the mesenteric microenvironment as transplantations 
of peripheral nonmucosal lymph nodes within the gut mesenteries does not result in 
imprinting of gut homing receptors on T cells, even though SI LP DCs can populate the 
graft 124,125. 
PPs are lymphoid aggregates that develop embryonically. They are covered by 
specialized epithelium, called follicle-associated epithelium (FAE). PPs contain germinal 
centers, where IgA B cells develop in a T cell-dependent manner. PPs are found 
throughout the small intestine but are more pronounced in the terminal ileum, where 
bacterial loads are greater. In contrast to MLNs, PPs do not have afferent lymphatics, but 
instead acquire antigens directly from the lumen through M cells. M cells deliver the 
antigens to DCs localized underneath, in the subepithelial dome 126. PPs also play a role 
in oral tolerance and may deliver antigens via efferent lymphatics to MLNs 126,127.   
ILFs are small lymphoid aggregates, generally containing a single germinal 
center. They develop after birth, progressively, from even smaller lymphoid aggregates 
known as cryptopatches, in response to commensal and stromal cell-derived signals 128-
131. Within ILFs, B cells can class switch to IgA in the absence of T cells 128. IgA B cells 
generated in ILFs and PPs migrate to MLNs to differentiate into IgA-secreting cells, 
which then home to the lamina propria to release secretory IgA 128.  
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C. Control of intestinal CD4 T cells differentiation by MNP subsets 
 
1. Th1 cells 
 Classical Th1 cells are primed with antigens derived from intracellular bacteria 
and viruses and respond to type I and II interferons and IL-12. These cytokines trigger the 
sequential activation of STAT1 and STAT4 and finally, the induction of the master 
transcriptional regulator T-bet and the signature cytokine, IFNγ 132-134. Th1 cells express 
CCR1, CCR5 and CXCR3, which allow them to traffic to inflammation sites 135. In 
addition to their ability to control infections with intracellular pathogens such as 
Toxoplasma gondii 136, Th1 cells have also been implicated in various autoimmune 
inflammations, including inflammatory bowel diseases 94,137,138.   
 While Th1 cells are represented in the LP of both SI and colon at steady state, the 
exact signals that trigger their development, the role of GALT in the priming of these 
cells as well as their function at steady state are not so clear 135,139-142. Colonization of GF 
mice with Bacteroides fragilis, a human-specific gram-negative commensal, polarizes 
CD4 T cells towards a Th1 phenotype, although IL-10 producing Tregs are also induced 
in the gut143. B. fragilis-derived Polysaccharide A (PSA) induces Th1 cell differentiation 
via stimulation of IL-12 secretion by CD11c+ cells and PSA antigen presentation 
underscoring the significance of innate immune pathways in Th1 cell development 143. 
Among intestinal MNPs, CD103 SP DCs are proposed to be the main inducers of SI Th1 
responses and cytotoxic T lymphocyte activity in vivo144. To induce Th1 responses, 
CD103 SP DCs produce IL-6 and IL-12p40 following ligation of TLR3, TLR7, and 
TLR9144. Moreover, CD103 SP DCs are crucial for mounting protective Th1 responses to 
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Trichuris muris in MLN93. Similarly, ablation of colonic CD103 SP DCs in DT-treated 
Clec9A-DTR mice leads to severe colitis because of deficient IFNγ-dependent activation 
of anti-inflammatory genes in IECs145. In contrast, during colitis Ly6chi monocytes 
develop into proinflammatory CD103-CX3CR1intCD11b+ DCs, which accumulate in the 
LI LP, secrete IL-12, IL-23, and iNOS and drive differentiation of IFNγ-producing Th1 
cells60. During intestinal infection, intestinal epithelial tissue damage leads to leakage of 
commensal antigens into the lamina propria, which drives both pathogen-specific effector 
Th1 cell differentiation and commensal-specific memory Th1 cell development 146. 
Therefore, different mechanisms of induction and MNP subsets are required for driving 
Th1 cell differentiation at steady state and during inflammation.      
 
2. Th2 cells 
 In neonatal and germ-free animals, intestinal effector CD4 T cells are biased 
towards Th2 lineage. Early life microbial colonization leads to a significant 
underrepresentation of this lineage, probably because of lack of infection with intestinal 
helminths in specific pathogen-free mice 135,143,147. Classical Th2 cells develop in 
response to parasitic helminths and possibly other extracellular microbes that stimulate 
innate immune cells to produce IL-4, which trigger activation of STAT6 and induction of 
the master transcription regulator GATA3 148,149. Fully differentiated Th2 cells then 
induce production of IL-4, IL-5, and IL-13 effector cytokines, as well as expression of 
chemokine receptors CCR3 and CCR4 133,150. Th2 cells can also affect systemic immunity 
by mediating the pathology of allergic responses and asthma. In this regard, allergic Th2 
responses to orally delivered peanut antigens are driven by IL-4 produced by activated 
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CD4 T cells. Although the specific LP MNP subset that promotes T cell-intrinsic IL-4 
secretion is unknown, signaling through OX40L expressed on LP DCs appears to control 
IL-4 production151. More recent reports propose a role for IRF4-dependent DCs in lung 
Th2 differentiation and CD301b+ dermal DCs in Th2 skin immunity. Their intestinal DC 
counterparts, however, are unclear152,153.   
 
3. Th17 cells 
i. Commitment to Th17 cell lineage 
Th17 cells are important for clearance of extracellular pathogens and for 
promotion of tissue repair via the signature cytokines IL-17A, IL-17F, and IL-22. Th17 
lineage specific cytokines regulate granulopoiesis, recruit neutrophils, induce 
antimicrobial peptide production, and promote anatomical containment of microbes 154-
156. In addition, intestinal Th17 cells exacerbate the severity of several organ autoimmune 
diseases 157. Th17 cells develop in response to extracellular bacteria and fungi under the 
combined action of IL-6 and TGFβ1 and self-maintain via autocrine signaling from IL-21 
and IL-1β 147,158-161. Cytokine receptor engagement activates STAT3, which upregulates 
the master transcriptional regulator RORγt 154,162 with help from several transcription 
factors163 including IRF4 164,165, Batf 166, c-Maf167, Ahr 168,169, and RORα 170. During the 
early phase of differentiation, Th17 cells secrete IL-21, while during the last phase they 
upregulate IL-23 receptor and secrete the signature effector cytokines, IL-17A, IL-17F 
and IL-22 171,172. Th17 cells co-express CCR6 and CCR4 173, which promote recruitment 
to inflammatory sites. In experimental autoimmune encephalomyelitis (EAE), lack of 
CCR6 on Th17 cells decreases severity of disease 174. Despite their enrichment at 
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intestinal sites, Th17 cells do not express unique gut homing receptors. In fact, exposure 
to retinoic acid, the inducer of gut tropism, suppresses their fate and skews activated CD4 
T cells towards a FoxP3+ regulatory T cell lineage 120. 
 
ii. Th17 cell-inducing cytokines 
Mice deficient in IL-6 or carrying a mutated form of TGFβ1 confirmed the 
dominant role that these cytokines play in driving Th17 cell differentiation in vivo 
158,159,175,176. However, IL-6 may not be absolutely required, because RORγt+ CD4 T cells 
can develop in IL-6-/- mice 177.  A definitive requirement for most other cytokines is 
unclear. Despite the fact that IL-21 was reported to be necessary for optimal Th17 cell 
differentiation ex vivo and in peripheral lymphoid organs 178, IL-21-/- animals display an 
increased number of Th17 cells in the SI LP 175. Because IL-21 appears to promote IL-10 
production, it is possible that lack of IL-21 results in enhanced Th17 cell levels due to 
reduced suppression by IL-10 135. In addition, IL-21 is pathogenic in both acute and 
chronic models of colitis 178-180. Although IL-23 is necessary for the late stages of Th17 
cell development 154,181,182, absence of IL-23 does not impede Th17 cell differentiation at 
steady state in SI LP 175, but it confers protection during infection with Citrobacter 
rodentium in LI LP 159. IL-23 may decrease production of IL-22 by Th17 cells in the SI 
175. In addition, IL-23 may play a role in Th17 cell development in LI, where its levels are 
negatively regulated by IL-25. In this case, IL-25 deficiency leads to increased numbers 
of Th17 cells through enhanced transcription of IL-23p19 183. Several reports converge 
on a role for IL-23 in promoting development of pathogenic Th17 cells as various 
methods of abrogating IL-23 levels or signaling reduce symptoms of colitis 184-187, EAE 
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188, psoriatic arthritis and psoriasis 189,190, and rheumatoid arthritis 191. In addition, IL-23 
signaling promotes induction of IL-17A and pro-inflammatory chemokines by newly 
differentiated Th17 cells without upregulating IL-10 production, reinforcing its role of 
supporting pro-inflammatory responses 192. IL-23 also stimulates production of TGFβ3 
from developing Th17 cells, which together with IL-6 subverts the differentiation 
program towards pathogenic Th17 cells193. IL-23 is thought to promote GM-CSF 
production by Th17 cells to confer pathogenicity during EAE 194,195 and colitis 196. In 
these contexts, GM-CSF may act in a paracrine manner since GM-CSF-deficient T cells 
can still induce disease 197.   
 
iii. Microbe-mediated Th17 cell induction 
In the steady state, Th17 cells preferentially reside in the SI LP, and to a lesser 
extent in the colon162,198. Their development relies on the presence of intestinal 
microbiota and they are specifically induced in the terminal ileum of mice colonized with 
segmented filamentous bacteria (SFB) 147,175. Specific-pathogen free mice (SPF) mice 
raised at The Jackson Laboratory carry no SFB and have very low levels of Th17 cells, 
whereas certain SPF mice raised at Taconic farms are enriched for SFB and have high 
Th17 cell levels 175. Germ-free mice and antibiotic-treated conventional mice have 
decreased levels of Th17 cells in the SI LP 175,199. Colonization of germ-free or Jackson 
SPF mice from with SFB recovers the levels of IL-17A and IL-22-secreting Th17 cells in 
SI 147. We find that the cognate antigens for the majority of SFB-induced Th17 cells are 
SFB-derived and are presented by LP CD11c+MHCII+ cells. In addition, SFB-mediated 
Th17 cell differentiation can only be driven by host-specific SFB through adhesion to 
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host IECs200. Adhesion to intact, but not disrupted, IECs appears to be a prerequisite for 
Th17 cell induction in both SI and LI LP by any microbe, including Citrobacter 
rodentium, EHEC O157:H7, and Candida albicans200. It will be interesting to identify the 
molecular signature of TH17 cells induced by non-mucosa associated commensals.  
Microbiota-mediated TLR9 signaling has also been shown to promote 
inflammatory Th17 cell induction in the small intestine 201. Specifically, stimulation of 
TLR9-expressing LP DCs with CpG-rich motifs derived from commensal DNA leads to 
increased generation of IFNγ and IL-17 producing effector T cells and concomitantly, to 
decreased levels of pTregs within the SI GALT and LP 201. Hence, commensal-derived 
DNA motifs trigger IL-6 production from TLR9-expressing LP DCs, and tip the balance 
in favor of effector T cell differentiation. We and others identified a negative regulatory 
loop between MHCII-expressing ILC3 cells and Th17 cells, which occurs independently 
of SFB status. Specifically, we found that lack of MHCII on ILC3 in RORγtΔMHCII leads 
to higher levels of commensal-dependent Th17 cells 202. Further studies revealed that 
ILC3 cells limit commensal-specific CD4 T cell responses via MHCII interactions that 
resemble thymic negative selection 203,204. 
 In the colon, Th17 cell levels increase with age and occur at normal levels in PP 
and colonic patch-null mice 199. Furthermore, colonic Th17 cells are preferentially 
induced in response to bacterial-derived ATP. This effect is mediated by colonic 





4. Regulatory T cells 
Within the antigen-rich intestinal environment, effector Th cells run the risk of 
mounting responses to self antigens and triggering inflammation and autoimmune 
diseases. Thymus-derived natural regulatory T cells (tTregs) and peripherally-induced 
Tregs (pTregs) represent populations of CD4 T cells that suppress overt effector Th 
responses by inhibiting T cell proliferation. At steady state, tTregs and pTregs can be 
distinguished through the expression of Helios and neuropilin1 (Nrp1) with pTregs 
displaying low to undetectable levels of these markers, though, during inflammation such 
as EAE, pTregs may also upregulate expression of Nrp1 205,206. 
The master regulator of Tregs is the transcription factor FoxP3, which is induced 
in naive CD4 T cells in the periphery by high levels of TGF-β207,208. Although both Th17 
cells and FoxP3+ Tregs require TGFβ and retinoic acid during the initial steps of their 
development, IL-6 and IL-21 inhibit TGFβ-induced upregulation of FoxP3 and skew 
CD4 T cell differentiation towards Th17 cell fate. In addition, SI LP hosts FoxP3- 
regulatory cells, Tr1-like cells 209. Both FoxP3+ pTregs and FoxP3- Tr1-like cells produce 
large amounts of the anti-inflammatory cytokine IL-10 210,211. Although FoxP3+ pTregs 
and IL-10-expressing CD4 T cells may have non-redundant functions, FoxP3ΔIL-10 and 
FoxP3ΔIL-10Ra mice develop spontaneous colitis underlining an important role for IL-10-
IL-10Ra axis in regulating Foxp3 Treg function 212,213.  
 GF mice have reduced numbers of colonic pTregs, but not SI pTregs 214. Treg-
inducing potential is restricted to certain members of the commensal microbiota. 
Exposure of GF mice specifically to 46 Clostridium strains is sufficient to drive 
development of colonic Helios-FoxP3+ pTregs and attenuate the development of DSS-
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induced colitis 214. Clostridium-driven pTreg induction does not require classical innate 
immune signaling 214. Instead, it is mediated by short-chain fatty acids produced by 
digestion of dietary fibers by Clostridium strains 215-217. In contrast, B. fragilis induces IL-
10 + Tregs via signaling through TLR2 expressed on FoxP3+ Tregs, independently of LP 
DCs218.  
 
V. Functions of intestinal mononuclear phagocytes 
A. Antigen uptake 
LP MNPs can pick up antigen transported across the intestinal epithelium or 
directly from the lumen (Figure 1-3). One prevalent route of antigen sampling is 
phagocytosis and transcytosis through specialized cells of the FAE of PPs known as M 
cells 219. M cells uptake a wide variety of macromolecules including food, environmental 
and microbial antigens through receptor mediated endocytosis or yet undefined 
mechanisms that involve immunosurveillance receptors expressed on their apical surface, 
such as glycoprotein 2, uromodulin, cellular prion protein and others 220. Following 
transcytosis through the FAE, bulk antigens exit into the subepithelial dome, where 
MNPs pick them up to present to nearby lymphocytes to induce mucosal immune 
responses. In Spi-B-/- mice, which lack the ability to induce maturation of M cells, 
antigen sampling is deficient and results in reduced expansion of antigen-specific T cells 
in response to infection with Salmonella typhimurium 221,222.  
 A second route delivers luminal antigens directly to the LP via neonatal Fc 
receptor (FcRn)-mediated bidirectional transport of IgG-antigen complexes 223. In this 
case, FcRn binds IgG in the LP, transports it through the IEC basolateral surface to the 
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apical surface, allows it to form complexes with its cognate antigen in the lumen, and 
transports the IgG-antigen complexes in the converse direction to CD11c+ LP cells for 
antigen processing and presentation 223.   
 A third route focuses on the constant immunosurveillance of the lumen by 
CD11c+ cells via extensions named transepithelial dendrites (TED), which establish tight 
junction-like structures with neighboring IECs and preserve the villus brush border 224-226. 
Rescigno et al also proposed that CD11c+ cells could employ TEDs to engulf exhausted 
and apoptotic epithelial cells to facilitate the renewal of the epithelial barrier without 
disrupting its integrity 224. Using CD11c and MHCII reporter mice, several reports 
confirm the formation of epithelium-penetrating dendrites in the small intestinal LP, 
however, they do not agree on the number and distribution of TEDs 225-227. Initial studies 
suggested that CX3CR1 expression conferred CD11c+ cells the ability to form TEDs and 
sample commensal and pathogenic bacterial antigens for mounting proper immune 
responses 228. In addition, while TEDs form at steady state, their number increases in the 
terminal ileum in the presence of invasive or non-invasive Salmonella typhimurium in a 
MyD88-dependent manner suggesting that microbial signals drive increased TED 
formation and luminal sampling 226. In CX3CR1gfp/gfp mice TED formation by CD11c+ 
cells and uptake of DsRed2-labeled non-pathogenic E.coli or non-invasive GFP-
expressing Salmonella typhimurium were impaired, while acquisition of antigens via M 
cells was unaltered 228. However, the extent to which TED-mediated sampling contributes 
to sensing of non-invasive microbes is not clear 225. CX3CR1 expression also does not 
seem required for TED formation and TED formation has also been observed in the 
absence of CX3CR1 in the proximal ileum suggesting that inflammatory stimuli or 
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antigen overload can bypass the requirement for CX3CR1 expression for initiation of 
antigen sampling 226,229. 
  A fourth route relies on capture of low molecular weight soluble antigen by goblet 
cells (GC) and delivery through goblet cell-associated passages (GAPs) to 
CD103+CX3CR1- small intestinal DCs for induction of tolerogenic responses 227. Either 
by making stable contact with or by actively probing GAPs, CD103+ LP DCs, but not 
CD103- LP DCs, acquire soluble ovalbumin and cross-present it efficiently to OTI T cells 
in vitro. GAP-mediated delivery of antigen is preferred over direct sampling of luminal 
antigen as few transepithelial dendrites are observed after intraluminal injection of FITC-
dextran or ovalbumin 227. In addition, transfer of antigens between two different intestinal 
MNP subsets to induce oral tolerance has been reported 230. CD11b+CX3CR1+ cells were 
shown to extend dendrites to acquire luminal antigen, process it and deliver it to CD103+ 
DCs via connexin-mediated gap junctions 230. In the absence of gap junctions in 
CD11cΔCx43 mice, orally-fed ovalbumin protein accumulates in SI CD11b+CX3CR1+ 
phagocytes, which process it and successfully present it to OTII CD4 T cells ex vivo. 
  Antigenic material from MHCII-expressing epithelial cells could be transferred to 
LP DCs in the form of exosome-like vesicles named “tolerosomes” 231. These structures 
form by fusion of MHCII-carrying vesicles with endosomes containing luminal antigenic 
peptides and can reduce ear swelling in a delayed type hypersensitivity reaction 231.  
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Figure 1-3. Mechanisms of antigen sampling by intestinal MNPs.  
A. CD64 Mfs take up luminal antigens, process them and transfer them to conventional 
DCs via gap junctions for presentation. B. Both CD64 Mfs and CD24 DCs sample 
antigens from the lumen through transepithelial dendrites. Any MNP population can 
present the antigens and generate the appropriate cytokine milieu. C. IECs take up 
antigens by transcytosis. Unprocessed antigens are released at the basolateral surface via 
exocytosis or IEC-associated passages to MNP subsets. D. CD64 Mfs engulf dying IECs 
and process the microbial antigens that had been endocytosed by these IECs.    
 
B. Antigen processing and presentation 
Most studies focus on antigen uptake and presentation but little is known about how and 
where luminal antigens are processed for induction of mucosal immune responses. 
Orally-delivered antigens are presumably heavily processed by different physiological 
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factors they encounter en route to the intestinal lumen by processes such as low pH, 
digestive proteases, bile. This early processing can expose antigenic epitopes, which may 
facilitate their recognition, endocytosis or transcytosis, and further cleavage by 
specialized IECs and LP MNPs 232. With direct luminal antigen sampling, a reasonable 
assumption is that LP CD11c+ cells are equipped to both acquire and process antigens 
into peptides ready for display on MHCII molecules. In the case of antigen transfer from 
CD11b+ LP Mfs to CD11b+ LP DCs, Mfs engulf ovalbumin protein, process it into 
smaller peptides and deliver these peptides to LP DCs responsible for MHCII-dependent 
presentation 230. In support, although CX3CR1gfp/+ LP cells take up more ovalbumin 
protein in vivo than CD103+ DCs, they are less efficient at priming OTII CD4 T cells ex 
vivo 229. In cases of antigen overload, insufficient communication with or absence of 
CD103+ DCs, CX3CR1+ phagocytes can accumulate sufficient antigenic peptides, present 
and prime CD4 T cells 230. Whether similar antigen pre-processing occurs at all in 
specialized IECs prior to transfer to DCs it is not known. Of note, CD103+ SI DCs appear 
to receive full AlexaFluor647-labeled ovalbumin protein or FITC-dextran via GAP-
mediated transfer from GCs, which suggests that GCs do not process the soluble antigens 
they retrieve from the lumen 227. This finding confirms earlier studies of the ability of 
CD8+DEC-205+ and CD8-33-D1+ splenic DC to process and present antigens, which 
revealed their intrinsic bias towards MHCI-mediated cross-presentation and MHCII-
mediated presentation, respectively 233.  
 Intestinal MNP subsets differ in their ability to present antigens and prime CD4 T 
and CD8 T cells, although similarities to CD8+DEC-205+ and CD8-33-D1+ splenic DCs 
exist. Isolated CD103+CD11b- DCs have an enhanced capacity to cross-present antigens 
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to CD8 T cells, in vitro, similarly to their splenic counterpart of CD8+DEC-205+ DCs 
78,227. In addition, both ex vivo and in vivo studies show that all CD11c+MHCII+ LP MNP 
subsets can present antigen to CD4 T cells, albeit CD103+ DC subsets can do so more 
efficiently 61,64,78,230. Abundant ex vivo work revealed preferential presentation of dietary 
antigens by CD103+CD11b-, CD103+CD11b+, and some CD103- LP DCs 56,61,77,227, while 
bacterial antigen presentation is performed more extensively by CD103+CD11b+, CD103- 
CD11b+ LP DCs and CX3CR1+ Mfs 51,69,78,234-237. In addition, intestinal inflammation can 
dictate a switch from tolerogenic to immunogenic antigen presentation for CD103+ DCs 
238.  
 
C. Priming of CD4 T cells 
 As highlighted above, intestinal MNP subsets play a crucial role in initiation of 
CD4 T cell responses to luminal antigen. In the conventional response, MNPs become 
loaded with antigen within the LP or PPs and migrate to MLNs, where they prime newly 
arrived naive CD4 T cells for regulation of mucosal immune responses. A vast majority 
of studies reinforces the role of conventional DCs in priming CD4 T cells, which is 
related to their ability to migrate and bring antigens to MLNs. All LP DC subsets express 
CCR7, which is a chemokine critically required for migration of LP APCs to MLNs 51,106. 
Defective migration of DCs to MLNs in CCR7-/- mice results in impaired induction of 
pTregs and oral tolerance 107. Of note, antigen presentation by DCs is more important 
than innate immune activation mediated by DCs in mounting adaptive immune responses 
239. ZBTB46-mediated deletion of MHCII on all DCs led to reduced numbers of pTregs, 
lower levels of serum and fecal IgA and bacterial-mediated intestinal inflammation 239. 
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Among DCs, CD103+CD11b- LP DCs are most likely the main migratory subset that 
drives FoxP3+ pTreg differentiation and tolerance to oral antigens within the MLNs 77.  
 As described above, a lot is known about the role of LP DCs in priming of CD4 T 
cells, but the role of CD64 Mfs is less clear. Despite the low levels of CCR7 transcripts at 
steady state, some CD64 Mfs have been retrieved from the MLNs and FoxP3+ pTreg 
levels were reduced in MLNs of mice lacking monocytes and macrophages, MM-DTR 77. 
While priming of pTregs was not impaired in MM-DTR BM chimeras, the decreased 
pTreg levels suggest that antigen-loaded LP macrophages can either deliver cargo to LP 
DCs or migrate to MLNs and deliver their cargo to MLN DCs77. In fact, evidence for 
transfer of cargo between Mfs and DCs comes from gain-of-function experiments 
performed in Mycobacterium tuberculosis (Mtb) infected animals 240. In this case, transfer 
of MHCII-expressing CCR2+ inflammatory monocytes into MHCII-/- animals rescued the 
transport of Mtb antigens to the MLN without recovering priming of antigen-specific 
CD4 T cells 240. Interestingly, a similar mechanism may occur in the intestine in 
antibiotic-treated animals infected with non-invasive pathogens 236. In this microbial 
context, CX3CR1hi MNPs rather than CD103+DCs upregulate CCR7 expression and 
deliver heat-killed, non-invasive Salmonella to the MLNs 236. These results support a role 
for LP Mf migration to MLNs in cases of dysbiosis, where they may facilitate priming of 
CD4 T cells by classical DCs.  
 Where does CD4 T cell priming occur? Colonic Th17 cells numbers are normal in 
PP- and colonic patch-null, but MLN-sufficient mice, suggesting that colonic Th17 cell 
priming does not require PPs199. We and others also showed that CD11c+MHCII+ cells 
can prime SI Th17 cells in response to SFB in LTα-/- mice in the absence of GALT and 
35 
MLNs, suggesting that priming of mucosal Th17 cells can occur locally in the lamina 
propria202,241. In addition, colonic FoxP3+ pTregs are represented in normal proportions 
and are induced in normal numbers in LTα-/- mice, suggesting that colonic pTreg priming 
does not require GALT and MLN242. Interestingly, priming of SI FoxP3+ pTreg is 
defective in LTα-/- mice, hinting at different mechanisms of induction of SI and LI 
pTregs242. Because both SI Th17 cells and LI FoxP3+ pTregs are induced by commensal 
species (i.e. SFB and Clostridiales, respectively), an intriguing possibility is that 
commensal-driven mucosal T cells can bypass conventional priming in GALT and MLNs 
and instead, undergo priming locally in the lamina propria. As such, induction of certain 
commensal-specific T cell responses would occur in a distinct location from priming of T 
cells to oral antigens or pathogenic bacteria. It will be important to investigate whether 
such differential priming (i.e. in the MLN versus the LP) is employed in responses to 
different types of intestinal microbes (e.g., commensals vs pathogens or mucosa-adapted 
commensals such as murine SFB, murine Clostridiales vs other luminal commensal 
species).   
 
D. Induction of pTreg differentiation for oral tolerance 
 
Oral tolerance is a characteristic of intestinal immunity and refers to the local and 
systemic immune unresponsiveness to innocuous antigens administered orally.  
MLNs are sites of robust pTreg differentiation mediated by small intestinal CD103+ DCs 
118,121, and particularly CD103 SP DCs 77. Intriguingly, MLNs seem to be required 
differentially for the induction of FoxP3+Helios- Tregs in the SI compared to the LI. 
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Specifically, FoxP3+Helios- Tregs show impaired accumulation within the SI LP in LTα-/- 
mice compared to normal accumulation in LI LP 242. Similarly, ova-fed LTα-/- mice fail to 
induce FoxP3 pTreg differentiation of transferred OTII CD4+CD25- T cells in the SI but 
not LI, suggesting that priming of LI pTregs occurs locally within the LI LP 242. Key to SI 
pTreg differentiation and achievement of oral tolerance are migration of oral antigen-
loaded CD103+ DCs to the MLNs and imprinting of gut-homing receptors on activated T 
cells by these DCs 243. Subsequently, pTregs home to the SI LP where they undergo local 
proliferation in response to IL-10 production by CX3CR1+ macrophages and establish 
intestinal tolerance 244. Interestingly, CCR7-dependent migration of intestinal DCs to the 
MLNs may not be required for accumulation of normal numbers of pTregs within the SI 
or LI LP 242. In fact, CCR7-deficiency appears to nearly double the proportions of pTregs 
in both SI and LI LP. Because priming of SI pTregs is defective in the absence of MLNs, 
it is possible that another chemokine receptor-ligand axis acts redundantly with CCR7-
CCL19/21.      
  Most studies investigate oral tolerance using ovalbumin as a model oral antigen, 
however, other antigens such as tryptophan245 and curcumin246 have also been shown to 
induce tolerance and anti-inflammatory FoxP3+ pTregs.        
As mentioned previously, GCs can transfer Ova protein to CD103+ DCs via GAPs 
for cross-presentation to OTI cells.  In the process, CD103+ DCs also capture GC-derived 
proteins, which may be used to prime Tregs and induce suppression of T cell responses to 
self antigens 227. Thus, depending on the acquisition mode, CD103+ DCs may promote 
both oral tolerance and anergy of self-antigen-specific T cells.   
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E. Induction of pTreg differentiation by commensals 
 Intestinal MNPs induce pTreg differentiation in response to bacterial stimuli, in 
addition to diet-derived antigens. Work with human monocyte-derived dendritic cells 
showed that direct contact of DCs with individual members of commensal flora (i.e. 
Bacteroides and Bifidobacteria) induced DC maturation and a switch to a tolerogenic 
fate, which the monocyte-derived DCs employed to instruct differentiation of IL-10 
producing Tr1 cells 247. Similarly, MLN CD11c+ DCs loaded with B. fragilis-derived 
PSA can drive the differentiation of a mixture of Th1 and IL-10 producing Tregs that 
home to the colonic LP 143. Since commensals tend to adapt and evolve with the host, the 
above examples expose pTreg development pathways that are induced in response to 
non-host specific commensals. In this regard, 46 indigenous strains of Clostridiales can 
consistently induce robust Helios-FoxP3+ IL-10-producing CD4 T cells within the colonic 
LP that ameliorate colitis and reduce systemic IgE responses to OVA 214. Subsequently, 
bacterial metabolites that lead to colonic pTreg conversion were described. Short-chain 
fatty acids (SCFA), e.g. propionate and butyrate, produced during bacterial-mediated 
fermentation of dietary fibers or starches induced extrathymic FoxP3+ IL-10-producing 
Tregs 215-217. Administration of SCFA to GF mice was sufficient to induce upregulation of 
IL-10 and FoxP3 expression by activated CD4 T cells and to ameliorate T cell-driven 
colitis in lymphopenic mice 216,217. The role of intestinal MNP subsets was not 
specifically investigated in these studies 215. 
 Muscularis macrophages (MM) have been recently shown to express a 
transcriptional profile that resembles anti-inflammatory macrophages, suggesting they 
may function in tissue repair and wound healing 17. Specifically, infection with non-
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invasive Salmonella activates gut extrinsic sympathetic neurons, which trigger release of 
norepinephrine and stimulate β2 adrenergic receptors expressed on MMs to support 
transcription of Retnla, IL-10, Arg1 and Chi3l3 17. Whether the conversion of MMs into 
anti-inflammatory macrophages leads to pTreg-mediated suppression of overt immune 
responses and wound healing remains to be investigated. However, this finding provides 
an example of communication between enteric neurons and resident macrophages, in 
which neurons directly prime macrophages to perform anti-inflammatory functions in 
response to certain microbes. Neurotransmitters may act on dendritic cells to confer 
immunoregulatory potential to peripheral T cells. Vasoactive intestinal peptide (VIP) 
produced by intestinal enteroendocrine and immune cells suppress LPS-induced 
maturation of bone-marrow derived DCs and instead stimulate IL-10 secretion by 
BMDCs 248. VIP-imbued DCs promote differentiation of IL-10 and TGFβ-secreting Tr1-
like cells in vitro 248. Administration of VIP to a mouse model of relapse-remitting EAE 
leads to emergence of IL-10-producing FoxP3+CD4+CD25+ T cells from CD4+CD25- T 
that can accumulate in the perivascular cuffs and suppress proinflammatory T cell 
proliferation 249. Along the same lines, intravenous administration of BMDCs pre-treated 
with VIP during chemically-induced colitis ameliorates diseases by suppressing Th1-
driven responses, stimulating IL-10 and TGFβ production and inducing Tr1-like cells 250.   
    
F. Induction of Th17 cell differentiation 
 Which specific LP MNP subsets induce Th17 cell differentiation at steady state or 
inflammation is a topic of intense research. Both LP DC and LP Mfs have been reported 
to induce Th17 cell differentiation, however, these observations were largely based on 
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preferential induction of Th17 cells by sorted MNP subsets in vitro 64,66,199. Within the SI 
LP, DP DCs have been highlighted as the population responsible for induction of Th17 
cells both in vitro and in vivo 56,61,86,113. Endogenous Th17 cell levels were reduced in 
CD11cΔNotch2 animals, in which DP DC development is impaired, as well as in 
CD11cIRF4flox/- animals, in which DP DC survival and migration to MLNs are 
defective56,61,86. Similarly, SI and MLN Th17 cells were reduced in an ablation model of 
DP DCs (Langerin-DTA, 113). However, the role of DP DCs in initiation of microbe-
specific Th17 cell responses was not investigated.  In addition, it was unclear which MNP 
subsets generate Th17 cell polarizing cytokines and present antigens for induction of 
microbe-specific Th17 cell differentiation.  
 DP DCs are necessary for development of Th17 cell differentiation in response to 
pathogens or luminal commensals234,237. DP DCs promote Th17 cell differentiation 
through stimulation of pattern recognition receptors (PRR) such as toll-like receptors 
(TLR) 234,237. TLR5 ligation on SI DP DC (also defined as CD11chiCD11bhi cells) induces 
Th17 cell responses to Salmonella typhimurium and protects against lethal infection with 
the microbe234. In addition, Salmonella typhimurium flagellin stimulates IL-23 production 
from TLR5-expressing DP DCs, which enhances innate immune production of defenders 
IL-22 and RegIIIγ 235. TLR5 ligation on DP DCs by a commensal-derived flagellin 
(CBir1 flagellin) leads to CBir1-specific Th17 cell differentiation237. Of note, in 
conventional mice, CBir1 flagellin is heavily coated with IgA and does not translocate 
through the intestinal epithelial barrier. However, CBir1 flagellin delivered 
intragastrically to TCRβxδ-/- animals can penetrate into SI LP.  CBir1 flagellin-treated 
TCRβxδ-/- animals supported production of both IL-17 and IFNγ from adoptively 
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transferred CBir1 CD4 T cells, suggesting that this commensal induces a mixture of Th1 
and Th17 cell differentiation237. During colitis, CD103+ MLN DCs lose their tolerogenic 
properties and induce development of IFNγ and IL-17 producing CD4 T cells238. 
Similarly, DP DCs induce IL-17-producing CD4 T cells in LI LP of colitic Mucin-2-
deficient mice through generating high levels of IL-6 251. In addition, during infection 
with C. rodentium, CD11cΔNotch2 are susceptible to the pathogen and succumb to death 
during the adaptive immune response phase 87. Similarly, mice lacking all DCs, Flt3l-/- 
mice and Zbtb46-DTR BM chimeras, succumb to death during C. rodentium infection 87. 
Thus, CD103+ DCs and particularly, DP DCs, may induce Th17 cell differentiation in 
response to inflammatory microbe-driven gut environment. 
Although present in small numbers in MLN and LP, CD103- DCs have been 
reported to induce IFNγ and IL-17-producing CD4 T cells in the absence of overt 
stimulation78.  One subset of CD103- DCs, CCR2+CD103-CD11b+ DCs, was shown to 
preferentially induce Th17 cell differentiation through production of high levels of IL-
12/IL-23p40 but not IL-6 66. Whether CD103- DCs are involved in microbial antigen 
presentation for Th17 cell induction is not known. Furthermore, because they are GALT-
derived 78 it is unclear whether they preferentially function within the GALT or LP.    
CD64 Mfs may also be involved in Th17 cell differentiation both during 
infections and at steady state. While CD11cΔNotch2 mice are susceptible to infection with 
C. rodentium, Langerin-DTA mice are resistant arguing against a role for DP DCs in 
inducing Th17 cell immunity to the pathogen113. Cell-intrinsic Notch2 signaling is 
necessary for upregulation of CD11c expression on CD11c+CX3CR1-GFPhi LP cells, and 
LP Mfs promote secretion of IFNγ from Th1 and Th17 cells during C.rodentium 
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infection75,252. At steady state, commensals stimulate PRRs on SI CX3CR1+ Mfs, which 
instruct the Mfs to secrete IL-1β but not IL-6 69,177,237,253. Secreted IL-1β appears 
sufficient to drive SI Th17 cell development177. In addition, epithelial cell-derived IL-18 
antagonizes IL-1R signaling on CD4 T cells and limits colonic Th17 cell 
differentiation254. It is unclear whether a similar mechanism functions in SFB-driven 
Th17 cell differentiation. SFB can induce Th17 cell differentiation in the absence of TLR 
and IL-1R signaling147,199. In addition, colonic Mfs, defined as CD70+CD11c+ cells, can 
induce Th17 cell differentiation in response to commensal-derived, but not pathogen-
derived, ATP199. In fact, intraperitoneal or rectal administration of an ATP analogue into 
GF mice can rescue colonic Th17 cell levels to those observed in specific-pathogen free 
mice (SPF)199.  Overall, little is known about the role of MNP subsets in microbe-specific 
Th17 cell differentiation.  
 
VI. SFB-specific modulation of host immunity 
 
A. Segmented filamentous bacteria (SFB)  
SFB are the first example of a commensal species capable of modulating host 
adaptive immune response at steady state. SFB are spore-forming gram-positive 
anaerobic commensals that have segmented filamentous morphology and attach tightly to 
IECs exclusively in the terminal ileum 255. SFB are currently unculturable, although 
methods for their temporary propagation have been described256. Of note, colonization of 
germ-free mice with in vitro-propagated SFB resulted in high levels of luminal SFB and 
preferential attachment to caecal IECs rather than the terminal ileal IECs, which 
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underscores that additional optimization of the in vitro culture system is required.  SFB 
are widespread among vertebrates 257,258 and show host species-specific adaptations 259,260. 
Mouse and rat SFB genomes contain up to 10% strain-specific genes and orthologous 
proteins display 80% identity 261. Interestingly, single-cell sequencing revealed that even 
host-specific SFB genomes display some polymorphisms suggesting that genetic 
heterogeneity and potentially, distinct lineages/strains co-exist within a host 262. SFB 
possess a reduced genome of only 1.57 Megabases. Comparative metabolic pathway 
genome analysis reveals that SFB rely heavily on the host for basic metabolic functions, 
evidence for a mutualistic relationship with the host 261,263. The SFB genome is enriched 
for pathways that mediate communication with the environment and the host such as 
processes involved in interacting, acquiring and transporting metabolites from the lumen 
222. 
SFB colonization of the terminal ileum appears to reach a maximum during the 
time of weaning of mice and rats, after which their levels decrease rapidly264-266. The 
fluctuation in SFB levels was presumed to be due to dynamic changes in the levels of 
secretory IgA coated-SFB originating from mother’s milk and later, from self-produced 
secretory IgA in the small intestine 264-266. The changes in SFB levels pre- and post-
weaning in addition to their sensitivity to general antibiotic cocktails hampered the 
discovery of human SFB, especially since most human metagenome collections 
employed for comparison contain samples of low age and geographical location diversity 
222. More recent efforts aim to discover SFB in feces obtained from young children and 
young adults and reinforce the significance of timing, diet and health status of the human 
cohort 267,268.   
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B. SFB-mediated regulation of innate and humoral immune responses  
SFB have multiple immunomodulatory effects. SFB promote accumulation of 
intraepithelial lymphocytes and induce upregulation of MHCII molecules and 
fucosylation of glycolipids on SI IECs 269-271. SFB also induce production of 
antimicrobial peptides and stress response genes such as serum amyloid A proteins 
(SAA) 1-3 from IECs147,202. In addition, SFB have been shown to stimulate production of 
secretory IgA and enhanced generation of IgA+ plasma cells following interaction with 
IECs 198,200. IgA is the most abundant immunoglobulin isotype at mucosal surfaces and it 
mediates host intestinal immunity by coating pathogenic bacteria with high affinity 243.  
In line with these observations, SFB stimulate robust development of PP germinal 
centers. SFB can also drive development of tertiary lymphoid structures in the SI. Both 
lymphoid structures are employed by SFB as inductive sites for specific and non-specific 
gut IgA and Th17 cell responses272. SFB expand in the proximal third of the SI in the 
absence of secretory IgA in mice deficient for activation-induced cytidine deaminase 
(AID), which suggests that secretory IgA coating inhibits SFB attachment to the 
duodenum273. SFB-induced IgA+ plasma cells display different specificity and 
diversification profiles compared to E.coli -induced IgA plasma cells 272, which may 
contribute to the ability of SFB to modulate host response to infections with pathogenic 
bacteria. Secretory IgA coating of SFB is similar to that of bacterial drivers of colitis (i.e. 
Prevotellaceae, Helicobacter species). Specifically, it is the result of high affinity, 
antigen-specific, T-cell dependent antibody responses. SFB can exacerbate the 
development of rheumatoid arthritis and EAE 274,275. High secretory IgA coating of SFB 
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may contribute to regulating their levels and preventing overt inflammation. In contrast, 
most other commensal species are coated with low affinity IgA induced in a T-cell 
independent process 276.  
   
C. Innate recognition of SFB 
Microbes engage the innate immune system through pattern-recognition receptors 
(PRRs). PRRs recognize microbe-associated molecular patterns (MAMPs), such as 
lipopolysaccharide, flagellin, bacterial DNA, viral RNA, and fungal β-glucan. PRRs have 
crucial roles in protecting against pathogens, without inducing inflammation to gut-
resident commensals. PRRs fall into four categories: toll-like receptors (TLRs), NOD-
like receptors (NLRs), C-type lectin receptors (CLRs), and retinoic acid-inducible gene I 
(RIG-1)-like receptors (RLRs). TLRs are expressed either on the cell surface or in 
endosomes. TLRs activate adaptor molecules such as myeloid differentiation primary 
response 88 protein (MYD88) and TIR domain containing adaptor protein inducing IFNβ 
(TRIF). NLRs and RLRs are cytoplasmic proteins. NLRs signal through adaptor protein 
receptor-interacting protein kinase (RIPK), which activates similar downstream 
molecules to MyD88. CLRs are activated in response to fungi, whereas RLRs are 
involved in intracellular virus recognition. The PRR involved in SFB recognition remains 
unknown.  
Disruption of TLR or NLR signaling in Myd88-/-Trif-/-, MyD88-/-Tlr3-/-, Trif-/-, and 
Ripk2-/- mice does not impede Th17 cell development suggesting that SFB mediate their 
effects independent of TLR and NLR signaling 175,199. Commensal-derived ATP can 
induce colonic Th17 cell differentiation199. However, SFB-monoassociated mice have 
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lower levels of ATP in ileal and colonic contents than specific-pathogen free (SPF) mice, 
suggesting ATP is not required for SFB-mediated Th17 cell differentiation. It is possible 
that different PRR pathways act redundantly to facilitate Th17 cell differentiation by 
SFB. Thus, in the absence of all MyD88-dependent pathways, Ripk2-dependent 
mechanisms may take their place. However, absence of one PRR may not be sufficient to 
signal activation of redundant mechanisms and thus, Th17 cell differentiation would be 
impaired. In this regard, MyD88-dependent TLR9 sensing of commensal DNA alters the 
ratio of effector T cells to pTregs in the SI. It is not clear, however, whether this innate 
recognition affects SFB-mediated Th17 cell differentiation201. Overall, these results 
would suggest no requirement for IL-1β-IL-1R axis, which also signals through MyD88, 
but reduced levels of Th17 cells have been reported in MyD88-/- mice 177. In this case, IL-
1β was necessary and sufficient for Th17 cell differentiation as total LP cells from IL-1β-
/- or IL-1R-/- BM chimeras secrete low levels of IL-17A and IL-22 ex vivo 177. In addition, 
microbiota drive constitutive and high production of IL-1β by SI LP MNPs in 
conventionalized B6 mice, which correlates with normal levels of RORγt+IL-17A+ CD4 
T cells 200,277. Wildtype BALB/c mice, which produce less IL-1β than wildtype B6 mice, 
show reduced accumulation of Th17 cells in the presence of attached SFB 121. 
SFB attach tightly to IECs in the terminal ileum and trigger cytoskeletal 
rearrangements within the host epithelial cells278,279. Whether these rearrangements 
played a role in innate sensing of SFB was unclear.  In addition, it was not known which 
innate immune cells sense SFB moieties for generation of cytokine environment and/or 




VII. Commensal-specific effector T cell responses 
 Commensals drive development of distinct effector CD4 T cell lineages as GF 
mice have low numbers of Th17 cells in the SI LP and FoxP3+ pTregs in the LI LP, 
respectively147,214,280. Development of effector CD4 T cell responses requires both 
MHCII-mediated presentation of cognate antigen and an effector lineage-skewing 
cytokine environment. Prior to my thesis study, much was known about the role of 
cytokine environment in induction of effector T cell responses, but it was unclear whether 
microbial antigen presentation was necessary. In addition, the geography in which 
priming and differentiation of commensal-specific effector CD4 T cells occurs had not 
been examined.  
Antibiotic treatment depletes even the low levels of Th17 cells observed in SFB-
negative mice, suggesting that most if not all Th17 cells in the SI LP are induced by 
microbiota175,281. Most of the ensuing reports proposed that the commensal community or 
specific species induced cytokine environments conducive for development of Th17 or 
pTreg cells. Microbiota-induced cytokine environment was sufficient to activate naïve 
OTII CD4 T cells and drive Th17 cell differentiation in the presence of cognate antigen 
in vitro and ex vivo 56,61,64,66. In fact, LP Th17 cells developed even in the absence of 
cognate antigen, in Marilyn transgenic (Tg) mice, which recognize an MHCII-restricted 
self-male antigen, and in TCR7 Tg mice, which recognize an epitope from hen egg 
lysozyme 282. Commensal-derived DNA motifs preferentially induced Th17 cells via 
TLR9 stimulation201. In the colon, commensal-derived ATP drove colonic Th17 cell 
differentiation199. Direct ligation of TLR2 on effector CD4 T cells by B. fragilis PSA led 
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to induction of IL-10-producing FoxP3+ pTregs283. In addition, Clostridial species-
derived butyrate and propionate promoted differentiation of FoxP3+ pTregs215-217. In the 
case of SFB, SFB-induced SAA proteins facilitated Th17 cell differentiation147. 
Specifically, co-culture of splenic CD4 T cells with LP CD11c+ in the presence of 
recombinant SAA protein induced Th17 cell-specific transcriptional changes in activated 
CD4 T cells. These changes phenocopied the cytokine profile of in vivo activated Th17 
cells through production of IL-17A, IL-17F, IL-22, IL-21 but not IFNγ 147. These 
findings suggested that cytokine environment was necessary and potentially sufficient for 
induction of Th17 and pTreg differentiation. 
Whether microbiota induces microbe-specific T cell responses was not fully 
understood. In this regard, it was demonstrated that most of the TCRs carried by colonic 
pTregs had a distinct repertoire than those of effector FoxP3- T cells or of FoxP3+ Tregs 
isolated from spleen or MLNs284. These TCRs were proven to be specific for bacterial 
antigens. In addition, pTreg TCRs were associated with suppressive immune responses as 
transfer of these TCRs onto effector CD4 T cells induced colitis. Whether these 
commensal-specific TCRs induce the development of tTregs is unclear284,285. 
Nevertheless, this finding raised the possibility that in addition to exposure to non-self 
antigens in the thymus, effector CD4 T cells were instructed in the periphery with non-
self antigens derived from commensals. In support of peripheral education of T cells, 
FoxP3+RORγt+ CD4 T cells did not develop in SI LP of Marilyn and TCR7 Tg mice in 
the absence of cognate antigen282. 
Despite the fact that SI Th17 cells developed to normal levels in Marilyn and 
TCR7 Tg animals, it was unclear whether SFB-induced Th17 cells recognize SFB 
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moieties in conventional mice at steady state. In general, it was unclear whether 
commensal-specific T cells developed and were maintained in the mucosa. The mucosal 
epithelium acts like a firewall preventing translocation of luminal commensals into the 
lamina propria. However, gastrointestinal infections with invasive pathogens such as 
Toxoplasma gondii damage the epithelial barrier and lead to translocation of commensal 
bacteria into the LP146,286. In fact, infection with this pathogen led to development of 
effector Th1 cells specific for commensal Cbir1 flagellin along with those specific for 
pathogen-derived antigens142. During infection, the CBir1-specific Th1 cells were 
protective by facilitating clearance of the pathogen. However, CBir1-specific Th1 cells 
persisted long-term in the SI and showed rapid re-activation upon secondary encounter 
with CBir1 antigen leading to development of immune responses against the commensal. 
These findings proposed the existence of naïve commensal-specific CD4 T cells at steady 
state, which can become activated during acute infections. These results also raised the 
question whether commensal-specific responses developed against all commensal 
antigens or only towards the most abundant or accessible antigens. In addition, the impact 
that commensal-derived antigens could have on local and systemic responses over time 
was unclear.  
In the studies mentioned above, LP MNP cells play a role in generating a Th1, 
Th17 or pTreg-conducive cytokine environment or in delivering antigens for priming of 
commensal-specific CD4 T cells. However, it was not explored whether specific LP 
MNP subsets are required for commensal-specific mucosal T cell responses. The precise 
location of commensal antigen presentation and priming of CD4 T cells was also not 
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investigated. Furthermore, it is unclear whether commensal-specific effector T cells differ 
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How commensal microbiota contributes to immune cell homeostasis at barrier surfaces is 
poorly understood. Lamina propria (LP) T helper 17 (Th17) cells participate in mucosal 
protection and are induced by commensal segmented filamentous bacteria (SFB). Here 
we show that MHCII-dependent antigen presentation of SFB antigens by intestinal 
dendritic cells (DCs) is crucial for Th17 cell induction. Expression of MHCII on CD11c+ 
cells was necessary and sufficient for SFB-induced Th17 cell differentiation. Most SFB-
induced Th17 cells recognized SFB in an MHCII-dependent manner. SFB primed and 
induced Th17 cells locally in the LP and Th17 cell induction occurred normally in mice 
lacking secondary lymphoid organs. The importance of other innate cells was unveiled by 
the finding that RORgt+ innate lymphoid cells (ILCs) strongly inhibited SFB-independent 
Th17 cell differentiation in an MHCII-dependent manner. Our results outline the complex 


















A. Microbiota-induced intestinal Th17 cells are selected on MHCII 
 
SFB preferentially increase Th17 cell proportions in the SI LP (147 and Figure 2-S1A). To 
examine the dependence of intestinal microbiota-induced Th17 cells on MHCII we 
analyzed intestinal CD4 T cell homeostasis in MHCII-deficient mice (IAb-/-). IAb-/- 
animals have greatly decreased numbers of CD4 T cells due to lack of selection on 
MHCII. However, a small subset of CD4 T cells is still present in spleen and lymph 
nodes 287,288. The small and large intestinal lamina propria of IAb-/- animals contained a 
substantial CD4 T cells population (Figure 2-1A). The CD4 T cell population in IAb-/- 
animals contained an expanded proportion of Foxp3+ Treg cells in all tissues examined 
(Figure 2-1A and 2-S1B). In contrast, SI LP Th17 cells were decreased in SFB-positive 
IAb-/- animals compared to WT controls (Figure 2-1A). To examine whether Th17 cells in 
IAb-/- mice are controlled by SFB we compared T cell subsets in the presence and absence 
of SFB. Th17 cell numbers varied greatly in IAb-/- mice (Figure 2-1B). However, in 
contrast to WT mice, SFB-positive IAb-/- mice did not have significantly increased Th17 
cell percentages in the gut (Figure 2-1B). Therefore, even though Th17 cells can be 
generated in the absence of MHCII, SFB do not induce further Th17 cell differentiation 
in MHCII-deficient animals.  
 IAb-/- mice possess diverse, but quite distinct CD4 T cell repertoire 289. In order to 
examine if MHCII expression is required for SFB-mediated induction of WT Th17 cells, 
we performed adoptive transfer experiments. We first established that adoptively 
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transferred WT CD4 T cells develop into Th17 cells in the SI LP in an SFB-dependent 
manner. Indeed, donor WT CD4 T cells were easily detected in the SI LP of SFB-
negative and SFB-positive recipients, but acquired IL-17 expression only in SFB-positive 
recipients, similarly to endogenous CD4 T cells (Figure 2-1C,D). Purified naïve CD4 T 
cells also generated Th17 cells only in the SI LP of SFB-positive hosts (Figure 2-S1C,D). 
We next transferred WT CD4 T cells into SFB-positive WT and IAb-/- recipients. WT 
CD4 T cells were detected in large numbers in the SI LP of IAb-/- recipients but did not 
generate any Th17 cells even in the presence of SFB (Figure 2-1E,F). Identical results 
were obtained after transfer of purified naïve CD4 T cells (Figure 2-S1C,D). Collectively, 
these data demonstrate that the induction of LP Th17 cells by SFB requires MHCII 
expression in the periphery. 
 
B. SFB-induced intestinal Th17 cells recognize SFB antigens 
 
SFB presence does not promote Th17 cell differentiation in MHCII-deficient CD4 T 
cells, suggesting that SFB provide more than just specific cytokine environment. We, 
therefore, examined SFB effects on Th17 cell induction in two TCR Tg models – OTII 
and TRP-1, which recognize peptides from chicken ovalbumin (OVA) and mouse 
tyrosinase related protein 1 (TRP-1) respectively 290. We first examined OTII mice on a 
RAG-sufficient background. These mice contained large number of CD4 T cells in the 
LP and a high proportion of these cells expressed IL-17 in SFB-positive mice, and even 
in the absence of OVA (Figure 2-S2A). In contrast to spleen and MLNs, CD4 T cells in 
the gut contained a large fraction of non-Tg TCRs as demonstrated by the low proportion 
54 
of Va2hiVb5hi Tg CD4 T cells (Figure 2-S2B). We therefore used this selection against 
transgenic TCRs in the LP to compare the re-programming of these cells to Th17 cells in 
comparison to cells expressing alternative TCRs. As shown on Figure 2-S2A, Va2hiVb5hi 
Tg CD4 T cells expressed very little IL-17, compared to the remaining CD4 T cells, even 
after activation with the cognate antigen (OVA). In agreement with this result, virtually 
all IL-17 expressing cells in the LP, expressed alternative TCRs, demonstrating an 
exclusion of Tg TCRs at the expense of endogenously formed TCRs with broad antigenic 
specificities in the Th17 cell subset (Figure 2-S2C). As a result, purified intestinal IL-17+ 
CD4 T cells from OTII.B6 Tg mice responded equally well to OVA and to SFB antigens, 
in sharp contrast to lymph node CD4 T cells, which responded to OVA only (Figure 2-
S2D). These results demonstrate that the intestinal Th17 cell population in OTII.B6 Tg 
mice is enriched for non-Tg specificities, due to favorable co-expression of non-
transgenic TCRs. They also suggest that non-SFB Tg T cells, e.g. OTII cells, are not 
efficiently induced into the Th17 cell lineage by SFB.  
To more directly examine the effects of SFB on non-SFB Tg T cells, we 
examined TCR Tg animals on a RAG-deficient background, which lack alternative 
endogenous TCRs. In both, OTII.RAG and TRP-1.RAG Tg mice small numbers of Tg T 
cells were present in the SI LP in the absence of the cognate antigen, but none of these 
cells expressed IL-17 even after SFB colonization (Figure 2-2A and 2-S2E,F). LP Tg T 
cells were activated and expanded following administration of cognate antigen, which 
also led to induction of effector Th1 and Th17 cells (Figure 2-2A and 2-S2E,F). 
However, even in the presence of the cognate antigen, SFB colonization did not induce 
further conversion of Tg T cells into Th17 cells (Figure 2-2A). Moreover, SFB 
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colonization did not induce Th17 cell differentiation of TRP-1.RAG Tg CD4 T cells 
transferred into WT mice separately or together with WT CD4 T cells, despite 
considerable expansion and activation of the Tg T cells and despite the presence of 
endogenous SFB-induced Th17 cells and induction of Th17 cell differentiation in co-
transferred WT cells (Figure 2-S3A,B). Combined, these experiments demonstrate that 
SFB-conditioned intestinal environment is not sufficient to induce IL-17 expression in all 
activated CD4 T cells.  
We next examined whether SFB-induced Th17 cells preferentially respond to 
SFB. We isolated CD4 T cells from SI LP of SFB-positive and SFB-negative WT mice 
and compared their response to SFB antigens ex vivo. Purified SI LP CD4 T cells from 
SFB-positive WT mice responded to SFB antigens, while SI LP CD4 T cells isolated 
from SFB-negative mice, did not (Figure 2-2B). In contrast, SI LP CD4 T cells from 
SFB-positive and SFB-negative mice did not respond significantly to a number of non-
SFB bacteria, including Gram-negative E. coli, Gram-positive Clostridium perfringens, 
and cultured murine intestinal isolates (Figure 2-2C), demonstrating that LP CD4 T cells 
from SFB-positive animals are specifically enriched for SFB reactivities. The SFB-
specific response required antigen presenting cells and MHCII expression, because 
purified WT SI LP CD4 T cells from SFB-positive mice did not respond to SFB antigens 
in the absence of DCs or when co-cultured with MHCII-deficient DCs as antigen 
presenting cells (Figure 2-2D and data not shown). 
To investigate directly the response of gut Th17 cells, we purified GFP+ (Th17) 
and GFP- (non-Th17) CD4 T cells from the SI LP of SFB-colonized Il17GFP reporter mice 
(Figure 2-S3C) and stimulated them in vitro with various bacterial lysates. Th17 cells 
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responded strongly to SFB, while non-Th17 cells did not respond to SFB above 
background (Figure 2-2E,F). The response of purified Th17 cells was specific to SFB, 
because the same cells did not respond significantly to cultured bacteria (Figure 2-2F). In 
response to SFB, all proliferated GFP+ cells continued to express IL-17 (GFP) (Figure 2-
S3G), in contrast to the small proportion of proliferated GFP- cells, which remained 
mostly IL-17- (Figure 2-S3G). Furthermore, LP Th17 cells did not respond to lysates 
prepared from feces of germ-free (GF) or SFB-negative conventionally raised mice (SPF) 
that contained similar numbers of total bacteria (Figure 2-2F) confirming that the 
response is SFB-specific. To examine whether the response is directed towards an 
antigen from SFB, as opposed to an SFB-induced host protein, we prepared lysates from 
SFB filaments purified by cell sorting (Figure 2-S3D). LP Th17 cells responded to sorted 
SFB filaments, while non-Th17 cells did not (Figure 2-S3E). We conclude that LP Th17 
cells respond to SFB-derived protein antigens. To examine whether the SFB-specific 
response in intestinal Th17 cells is directed by the presence of SFB, we purified GFP+ 
(Th17) cells from SI LP of Il17GFP reporter mice before and after SFB colonization and 
examined their response to SFB. In contrast to Th17 cells isolated from SFB-positive 
mice, Th17 cells from SFB-negative mice did not proliferate in response to the same SFB 
antigen preparation (Figure 2-2G). Similar results were obtained when Th17 cells were 
isolated on the basis of RORγt expression from SFB-positive and SFB-negative RorcGFP 
reporter mice (Figure 2-S3F). These results demonstrate that Th17 cells from SFB-
positive, but not from SFB-negative, mice preferentially recognize SFB antigens and are, 
therefore, enriched for SFB specificities.  
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C. Most lamina propria Th17 cells recognize SFB antigens 
 
The in vitro co-culture experiments showed that LP Th17 cells from SFB-positive mice 
respond to SFB antigens. However, the strong proliferative response in these experiments 
can be due to expansion of a small subset of clones within the starting Th17 population. 
To more directly quantify the proportion of LP Th17 cells that recognize SFB antigens 
we decided to query the TCR specificities of individual cells in the total LP Th17 
population. To this goal we generated a collection of T cell hybridomas from GFP+ 
(Th17) and GFP- (non-Th17) SI LP CD4 T cells, isolated from SFB-positive mice, and 
examined the response of individual clones to SFB and control bacteria. As shown on 
Figure 2-3A, 43 out of 94 hybridomas from LP Th17 cells, or 46%, responded to SFB. In 
contrast, only 3% of the non-Th17 cell hybridomas (3 out of 96) responded to SFB 
(Figure 2-3A). Most Th17 cell hybridomas responded strongly to SFB (50-100% of the 
maximum anti-CD3/anti-CD28 stimulation) and did not respond to E. coli or C. 
perfringens antigens (Figure 2-3B and data not shown). In comparison, the three positive 
hybridomas from non-Th17 cells responded weakly (5-35%), though specifically, to SFB 
antigens (Figure 2-3B). Taking into account that Th17 cells from SFB-negative mice do 
not respond to SFB antigens and that there is 5-7 fold Th17 cell increase upon SFB 
colonization, the hybridoma results show the presence of at least 55-57% SFB-reactive 
cells in the SFB-induced Th17 cell population. This response was diverse and polyclonal, 
as demonstrated by the sequences of SFB-responsive hybridomas (Table 2-S1). 14 out of 
15 sequenced SFB-responsive hybridomas had unique TCRb CDR3 junctions with 
diverse lengths (Table 2-S1). SFB-induced Th17 cells in vivo, as well as Th17 cell 
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hybridomas used a wide range of Vb gene segments, though we did note a relative 
abundance of Vb14 TCRs (Figure 2-S4 and Table 2-S1). We, therefore, conclude that 
most SFB-induced Th17 cells recognize SFB antigens and this SFB-specific Th17 cell 
response is diverse and polyclonal. 
 
D. MHCII expression on DC is necessary and sufficient for induction of Th17 cells 
by SFB  
 
MHCII expression in the periphery is required for SFB-mediated Th17 cell induction. 
We, therefore, next investigated the nature of the participating MHCII-expressing cells 
that present SFB antigens. Several types of MHCII-expressing cells exist in the LP. 
These include professional APCs, DCs and B cells, as well as other cell types, such as 
intestinal epithelial cells (IECs) and ILCs. To investigate the role of professional APCs, 
we first examined Th17 cell induction by SFB in the absence of B cells. Th17 cell 
induction after SFB colonization occurred normally in Cm-deficient mice 291, which lack 
mature B cells (Figure 2-S5H), demonstrating that B cells are not required for SFB-
mediated Th17 cell induction.  
To investigate whether MHCII-dependent antigen presentation by intestinal DCs 
is required, we generated mice with DC-specific ablation of MHCII (DCΔMHCII mice), by 
inter-crossing IAbflox mice 292 with CD11c-Cre mice 293 (Figure 2-4). All major LP 
CD11c+ subsets were present in DCΔMHCII mice in similar numbers, however they 
completely lacked MHCII expression (Figure 2-4A and Figure 2-S5A). In contrast, 
MHCII expression was present on CD11c-negative cells (Figure 2-4A), including IgA+ 
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plasma cells and B220+ B cells, though it was reduced on the latter (Figure 2-S5B).  
In the absence of SFB, DCΔMHCII mice had slightly increased Th17 cell percentage 
over control littermates (Figure 2-4B,C). SFB colonization induced robust Th17 cell 
differentiation in control animals. In contrast, SFB colonization did not lead to a 
statistical increase in Th17 cells in DCΔMHCII mice, even though SFB numbers and 
attachment were similar to the littermate controls (Figure 2-4B,C and Figure 2-S5F,G). 
Ablation of MHCII on DCs did not affect the expression of major Th17-inducing 
cytokines [e.g. IL-6, IL-23, transforming growth factor-b (TGF-b), IL-1b], or the 
induction of a number of other cytokines and enzymes, such as SAA1, SAA3, and iNOS, 
by SFB (Figure 2-4D and 2-S5C), demonstrating lack of major changes in the cytokine 
milieu. We conclude that MHCII expression on intestinal DCs is required for induction of 
Th17 cells by SFB. Consistent with our previous studies 147, SFB colonization did not 
affect Th1 or Treg cell proportions in WT or DCΔMHCII mice (Figure 2-S5D,E). Treg cell 
proportions were increased in the intestinal LP of DCΔMHCII mice, though, as previously 
reported 294, they were decreased in spleen and MLN, suggesting that MHCII expression 
on DCs may have different roles in Treg cell control in gut versus secondary lymphoid 
organs (Figure 2-S5E).  
 To examine whether MHCII expression on DCs is sufficient for induction of 
Th17 cells by SFB, we examined Th17 cell induction in mice in which MHCII 
expression is restricted to CD11c+ cells (MHCIICD11c mice) 295. Because MHCIICD11c 
mice lack MHCII expression on thymic epithelium and are deficient in CD4 thymic 
positive selection, we performed adoptive transfers. As in previous experiments, transfer 
of WT CD4 T cells led to an SFB-dependent Th17 cell induction in the SI LP, which was 
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abrogated in the absence of peripheral MHCII expression in MHCII-deficient recipients 
(Figure 2-4E,F). Transfer of WT CD4 T cells into littermate MHCIICD11c mice led to 
considerable induction of Th17 cells in the transferred cells, demonstrating that recovery 
of MHCII expression only on CD11c+ cells is sufficient to promote Th17 cell induction 
(Figure 2-4E,F).  
 Combined, these results show that MHCII expression on intestinal DCs is 
necessary and sufficient for SFB-mediated induction of Th17 cells.  
 
E. MHCII expression on ILCs controls intestinal Th17 cells  
 
Several other non-conventional antigen-presenting cell subsets express MHCII in the 
intestine. These include IECs and ILCs 203,296. MHCII expression on IECs has an 
unknown function and is controlled by commensal bacteria 270. Notably, MHCII 
expression on IECs was induced very specifically by SFB only in the terminal ileum 
(Figure 2-5A and data not shown). To investigate the role of IEC MHCII expression in 
SFB-mediated Th17 cell induction we generated IECΔMHCII mice, in which MHCII was 
deleted only on IECs by crossing IAbflox mice with Villin-Cre mice 297 (Figure 2-S6A,C). 
Colonization of SFB-free IECΔMHCII mice with SFB (Figure 2-S6A,B) led to induction of 
Th17 cells, similar to that in littermate controls (Figure 2-5B,C), demonstrating that 
MHCII expression on IECs is not required for this process. 
We also discovered that a subset of intestinal ILCs express MHCII (Figure 2-5D), 
as also reported recently 203. A large proportion of Lin-RORgt+ ILC3 cells express 
MHCII (Figure 2-5D). MHCII expression was most prevalent in c-kit+NKp46-RORgt+ 
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ILCs, and on only a small fraction of NKp46+ or c-kit- ILCs (Figure 2-5D and 2-S6D). To 
examine the role of MHCII expression on ILCs in SFB-mediated Th17 cell induction we 
generated ILC3ΔMHCII mice, in which MHCII was deleted only on RORgt+ ILCs by inter-
crossing MHCII-floxed mice with RORgt-Cre mice 298 (Figure 2-5D and 2-S6D,E). All 
three ILC3 subsets were present in ILC3ΔMHCII mice (data not shown). MHCII expression 
was completely ablated on Lin-NKp46-c-kit+RORgt+ LTi-like cells and significantly 
decreased in the small subset of MHCII+ cells within the remaining two ILC3 subsets 
(Figure 2-5D and 2-S6D). ILC3ΔMHCII mice did not demonstrate any signs of rectal 
prolapse or intestinal inflammation in our colony and MHCII deletion on ILC3s did not 
affect the percentage of SI LP Tregs (Figure 2-S6F,G). Surprisingly, in contrast to SFB-
free control littermates, which had low numbers of Th17 cells, ILC3ΔMHCII animals 
contained high percentage and numbers of SI LP Th17 cells even in the absence of SFB 
(Figure 2-5E,F). SFB-free ILC3ΔMHCII mice contained as many Th17 cells as SFB-
colonized WT littermates (Figure 2-5F). Colonization of WT mice with fecal bacteria 
from SFB-negative ILC3ΔMHCII animals did not induce Th17 cells, arguing against an 
outgrowth of other Th17 cell-inducing bacteria (Figure 2-S6H). In contrast to Th17 cells 
in SFB-positive WT animals, Th17 cells in SFB-negative ILC3ΔMHCII mice did not 
respond to SFB antigens in vitro (Figure 2-S6I). Colonization with SFB induced further 
increase in both percentages and total numbers of Th17 cells in 9-week old ILC3ΔMHCII 
mice (Figure 2-5F and Figure 2-S6J,K). In agreement with our observation that SFB 
induce SFB-specific Th17 cells, SFB colonization induced Th17 TCR repertoire changes 
in ILC3ΔMHCII mice, such as the induction of Vb14+IL-17+ CD4 T cells (Figure 2-5E and 
2-S6L), and a response to SFB antigens in vitro (Figure S6I). Collectively, these results 
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demonstrate that Th17 cells are increased in SFB-negative ILC3ΔMHCII mice, but SFB are 
still capable of inducing Th17 cells in these animals. 
 
F. Th17 cell induction by SFB does not require LN or organized GALT 
 
Our results show that SFB antigens are presented by iDCs in the context of MHCII to 
induce SFB-specific Th17 cells. To examine the site of Th17 cell priming in WT mice we 
analyzed the kinetics of SFB-mediated CD4 T cell proliferation and Th17 cell 
differentiation in different tissues following adoptive transfer (Figure 2-6). CD4 T cells 
were purified from spleens and LNs of Il17GFP reporter mice, labeled with proliferation 
dye and transferred into congenic WT recipients before or after SFB colonization. 
Proliferation was scored by dye dilution and Th17 cell differentiation by induction of 
GFP (IL-17) expression at different time points post transfer. A small number of 
proliferating transfer cells were first detected in the SI LP at Day 3 after transfer (Figure 
2-6A). The number of proliferating cells increased by Day 5 and some of those produced 
IL-17, again only in the SI LP, but not in spleen or MLN. By Day 7, transferred cells in 
SFB-colonized animals proliferated robustly and differentiated into Th17 cells in the SI 
LP. T cell proliferation and Th17 cell induction was dependent on the presence of SFB 
and was very low in SFB- animals (Figure 2-6A). In contrast, despite being present in 
larger numbers, very few transferred cells proliferated in the MLN at Day 7 and none 
expressed IL-17 (Figure 2-6A). Albeit lower than the SI LP, proliferation and Th17 cell 
induction was also observed in Peyer’s Patches (PPs) starting at Day 6 (Figure 2-S7). 
Further increase in proliferation and Th17 cell differentiation of transferred cells in the SI 
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LP was observed at 2 weeks post transfer (Figure 2-6B and data not shown). However, 
we did not detect significant proliferation or IL-17 expression in MLNs, iLNs, or spleen 
of SFB-colonized animals at any time-point, suggesting that SFB priming and induction 
of Th17 cells occurs in the small intestine itself (Figure 2-6B and data not shown).  
To investigate directly whether organized GALT is required, we examined the 
induction of Th17 cells by SFB in lymphotoxin-a (LTa)-deficient mice. Lta-/- mice 
possess a defect in generation of secondary lymphoid organs and lack PPs and isolated 
lymphoid follicles (ILFs) in the intestine, as well as peripheral lymph nodes, including 
MLNs. Lta-/- animals also lack LP B cells 299. Despite these defects, induction of Th17 
cells by SFB, including induction of Vb14+IL-17+ cells, was unimpeded in Lta-/- mice 
(Figure 2-7), demonstrating that organized GALT is not required for this process and 
confirming that LP B cells are also dispensable. Therefore, sampling of SFB antigens can 
occur outside Peyer’s Patches or MLNs and Th17 cell induction does not require priming 
in peripheral lymph nodes, suggesting that iDCs acquire SFB antigens and prime CD4 T 
cells locally in the LP.  
 Our results shed further light into the complex interactions involved in controlling 
intestinal Th17 cell homeostasis. Antigen presentation by MHCII plays central role in the 
induction of Th17 cells by commensal microbiota. Intestinal DCs acquire antigens from 
Th17 cell-inducing bacteria to promote antigen-specific Th17 responses locally in the 
lamina propria. At the same time, RORgt+ ILCs control excessive Th17 cell responses by 
inhibiting Th17 cell differentiation also in an MHCII-dependent manner. Further 
characterization of this process, such as identification of the participating SFB antigens or 
the involvement of specific subsets of DCs or ILCs, will help in better understanding the 
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molecular and cellular mechanisms involved in the host-commensal crosstalk regulating 





MHCII-floxed (IAbF/F), Cd11c-Cre, Vil-Cre, Cm-deficient, Il17GFP, TRP-1.RAG1 and 
Lta-/- mice were obtained from Jackson Laboratory. Rorc-Cre mice 298 were a gift from 
Dan Littman (NYU). MHCII-deficient (IAb-/-), OTII.B6 and OTII.RAG1 mice were 
obtained from Taconic Farms, the latter through the NIAID Exchange Program 300. 
MHCIICD11c mice (also known as CD11c-Abb mice) were previously described 295. All 
mice were bred and housed under specific pathogen-free conditions at Columbia 
University Medical Center. To control for microbiota and caging effects all experiments 
were performed with littermate control and gene-deleted animals housed in the same 
cage. 
 
SFB colonization and Th17 cell induction 
Bacterial genomic DNA isolation from fecal pellets and quantitative PCR for the SFB 
16S rRNA gene were performed as previously described 147. SFB colonization was 
performed by oral gavage with fecal pellets from SFB-monocolonized mice or with fecal 
pellets from SFB-negative Jackson B6 mice colonized with feces from SFB-
monocolonized mice unless otherwise noted. Control mice were gavaged with fecal 
pellets from SFB-negative littermates. SI LP Th17 cell induction was assessed 2-3 weeks 
after colonization. 
 
Activation of TCR Tg T cells 
To activate TCR Tg T cells, OTII.B6 and OTII.RAG Tg mice were fed 1% OVA protein 
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in the drinking water for 12 days. In addition the mice were orally gavaged with 50 mg of 
OVA protein (OVA, grade V; Sigma) on Day 1,3, and 5. TRP-1.RAG Tg mice were 
immunized i.p. with 50µg TRP1 peptide (CGTCRPGWRGAACNQKILTVR, 92% 
purity, Biomatik) in DPBS and 10µg LPS (Sigma-Aldrich) on Day 1 and 7. Control 
animals were immunized only with 10µg LPS in DPBS. 
 
Lamina propria cell isolation and adoptive transfers 
Lamina propria lymphocytes, intracellular cytokine staining, and Foxp3 staining were 
performed as previously described 175. For adoptive transfers, 5-10 x 106 MACS-purified 
CD4 T cells (Miltenyi Biotec; 95-98% purity) or 5 x 106 FACS sorted 
TCRb+CD4+CD62LhiCD44lo naïve T cells (BD Influx cell sorter) were transferred 
intravenously into Ly5.1 WT recipients before or 10-14 days after SFB colonization. 
Th17 cell induction in transferred cells in different tissues was assessed 2 weeks after 
transfer unless otherwise noted. In some experiments cells were labeled with CellTrace 
Violet proliferation dye (Life Technologies). 
 
In vitro co-culture experiments 
LP TCRb+CD4+ T cell subsets were purified by cell sorting and labeled with CellTrace 
Violet proliferation dye. 5 x 104 CD4 T cells were co-cultured in 96-well U-bottom plates 
with either 5 x 104 MACS purified splenic CD11c+ cells or 2 x 105 total TCRa-KO 
splenocytes as APCs in the presence or absence of autoclaved bacterial lysates. T cell 
proliferation was assessed 72 hours later by dye dilution. For SFB antigens, SFB 
filaments were purified from feces of SFB-monocolonized mice. Briefly, individual fecal 
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pellets from SFB-monocolonized mice were homogenized in PBS. The supernatant was 
cleared from debris by several low-speed centrifugations and bacteria were pelleted by 
centrifugation at 4,000g and washed twice with PBS. After the final wash the pellet was 
resuspended in PBS and layered onto 60% w/v Nycodenz density gradient. SFB filaments 
were collected at the interphase and the procedure repeated. Finally, the SFB filaments 
were washed twice in PBS. SFB and other bacterial antigens were prepared by 
autoclaving bacterial suspensions and used at 1:200 dilution.  
 
Hybridoma generation and screening  
FACS purified SI LP TCRb+CD4+GFP+ and TCRb+CD4+GFP- T cells were stimulated in 
vitro for 3 days in tissue culture plates coated with 5ug/ml each of anti-CD3 and anti-
CD28 mAbs, fused with BW5147 thymoma 301 and plated in limited dilutions in selective 
media. Individual clones were picked 10 days later and expanded in 24-well plates. The 
response of cloned hybridomas towards autoclaved bacterial lysates was measured using 
the HT-2 assay 302. In brief, 105 hybridoma cells were stimulated with plate-bound 
aCD3/aCD28 (positive control) or incubated with 105 bone-marrow-derived dendritic 
cells (or splenocytes from TCRα-KO mice) alone (no antigen control), or with SFB, E. 
coli, or Clostridium perfringens lysates. After 24  h, the amount of secreted IL-2 was 
measured with the detector HT-2 cell line. The proliferation of HT-2 cells in response to 
IL-2 was measured with the MTT (Sigma) assay 302, and the response for each 
hybridoma was plotted as percentage from the IL-2 response in the aCD3/aCD28-




Significance was scored by using unpaired two-tailed t test unless otherwise noted. P 
values were represented on figures as follows: ns, p ≥ 0.05, * p < 0.05, ** p < 0.01, *** p 
< 0.005, **** p < 0.001, ***** p < 0.0005, ****** p < 0.0001. Error bars on all figures 
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Figure 2-1. -Induction of intestinal Th17 cells by SFB requires MHCII expression in 
the periphery 
A. Th17 and Treg cell proportions in SI LP of SFB-positive WT and MHCII-deficient 
(IAb-/-) mice. Foxp3 and cytokine staining plots are gated on TCRb+CD4+ cells 
B. Th17 and Treg cell proportions in SI LP of SFB-negative (Jackson microbiota) and 
SFB-positive (Taconic microbiota) WT and IAb-/- mice. Plots gated on TCRb+CD4+ cells 
C-D. WT CD45.1+ CD4 T cells were adoptively transferred into WT CD45.2 mice before 
or 12 days after SFB colonization. Cytokine expression in host (CD45.2+) and donor 
(CD45.1+) SI LP TCRb+CD4+ cells 2 weeks after transfer. Data from one of multiple 
experiments 
71 
E-F. Th17 cell induction in WT CD4 T cells two weeks after transfer into SFB-positive WT and 




Figure 2-2. SFB-induced intestinal Th17 cells preferentially respond to SFB antigens 
A. Th17 cell proportions in the SI LP of OTII.RAG and TRP-1.RAG TCR Tg mice 
before and after SFB colonization in the absence or presence of cognate antigen. 
Representative data from 5 independent experiments 
B-C. Proliferation response of sorted SI LP TCRb+CD4+ cells from SFB-negative (Jax) 
and SFB-positive (Tac) WT B6 mice to SFB (B,C) or other bacterial antigens (C). T cell 
proliferation was scored by dye dilution on Day 3. Ec, E. coli, Cp, Clostridium 
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perfringens; MIB, mouse intestinal bacteria (cultured isolates from feces of SFB-negative 
(Jackson) mice); “-“ – no antigen. Representative data from 5 independent experiments 
D. SI LP TCRb+CD4+ cells were purified from SFB-negative (No SFB) and SFB-positive 
(SFB+) WT mice and co-cultured with SFB antigens as in (B) and WT or IAb-/- DCs. Data 
from 2 independent experiments 
E-F. SI LP GFP+ (Th17) and GFP- (non-Th17) TCRb+CD4+ cells from SFB-positive 
Il17GFP mice were stimulated in vitro with SFB (E,F) or various bacterial antigens (F) as 
in (B) or with lysates from germ-free (GF) or SFB-negative SPF (SPF) animals. 
Representative data from multiple experiments 
G. SI LP GFP+ (Th17) and GFP- (non-Th17) TCRb+CD4+ cells from SFB-positive 
(SFB+) or SFB-negative (No SFB) Il17GFP mice were stimulated in vitro with SFB 




Figure 2-3. Most intestinal SFB-induced Th17 cells recognize SFB 
T cell hybridomas were generated from SI LP GFP+ (Th17) and GFP- (non-Th17) CD4 T 
cells from SFB-positive Il17GFP mice. Data combined from 2 independent experiments 
A. Number of hybridomas responding to SFB  
B. Response of individual hybridomas (percentage of maximum anti-CD3 and anti-CD28 
stimulation) to SFB or E. coli antigens as assessed by IL-2 production. Clones were 
ordered in decreasing amounts of IL-2 production. 
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Figure 2-4. DC expression of MHCII is necessary and sufficient for SFB-mediated 
Th17 cell induction 
A. SI LP lymphocytes from DCΔMHCII and control littermates. Left panels, gated on 
TCRb-CD4- cells. Right panels, gated on CD11c+ cells 
B-C. Th17 cell induction in DCΔMHCII mice and control littermates 2 weeks after SFB 
colonization. Plots gated on TCRb+CD4+ cells. Representative data from 4 independent 
experiments 
D. Relative cytokine expression (RT-PCR) in terminal ileum of DCΔMHCII and control 
littermates (WT) 2 weeks after colonization with SFB. nd – below threshold of detection 
E-F. Th17 cell differentiation of WT CD45.1+ CD4 T cells in the SI LP 2 weeks after 
transfer into SFB-positive IAb+/-, IAb -/-, and IAbCD11c CD45.2+ recipient littermates. Data 
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from 2 independent experiments 
 
 
Figure 2-5. RORgt+ ILCs inhibit differentiation of SFB-independent intestinal Th17 
cells through MHCII 
A. MHCII expression on IECs in Jackson B6 mice before and 2 weeks after SFB 
colonization. Arrows point to SFB filaments attaching to IECs 
B-C. Th17 cell induction in IECΔMHCII mice and control littermates 2 weeks after SFB 
colonization. Plots gated on TCRb+CD4+ cells. Data from one of 2 independent 
experiments 
D. Expression of MHCII on SI LP c-kit+NKp46-RORgt+ group 3 ILCs in ILC3ΔMHCII 
mice and control littermates 
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E-F. Th17 cell induction in ILC3ΔMHCII and control littermates 2 weeks after SFB 
colonization. Plots gated on TCRb+CD4+ cells. Data from 2 independent experiments 
 
 
Figure 2-6. Priming and induction of Th17 cells by SFB occurs in the small intestine 
CellTrace Violet labeled CD45.2+ CD4 T cells from Il17GFP mice were transferred into 
WT CD45.1+ recipients before (No SFB) or after (+SFB) SFB colonization 
A-B. Proliferation (A,B) and Th17 cell induction (A) at indicated time points. Plots are 
gated on CD45.2+TCRb+CD4+ transferred cells. SI LP, small intestinal LP; MLN, 




Figure 2-7. SFB induce Th17 cells in the absence of secondary lymphoid organs 
SI LP lymphocytes were isolated from Lta-/- and control littermates 2 weeks after 
colonization with SFB 
A-C. Th17 and Vb14+IL-17+ cells induction in TCRb+CD4+ cells. Representative data 
from one of 2 independent experiments 





IL-1b Fw: 5'-CAACCAACAAGTGATATTCTCCATG-3' Rev: 5'-GATCCACACTCTCCAGCTGCA-3' 
IL-6 Fw: 5'-CCACTTCACAAGTCGGAGGC-3' Rev: 5'-TGCAAGTGCATCATCGTTGTTC-3' 
IL-17A Fw: 5'-GGACTCTCCACCGCAATGA-3' Rev: 5'-GGCACTGAGCTTCCCAGATC-3' 
IL-21 Fw: 5'-AAGATTCCTGAGGATCCGAGAAG-3' Rev: 5'-TGCATTCGTGAGCGTCTATAGTG-3' 
IL-23 p19 Fw: 5'-CTGGAACGCACATGCACCAG-3' Rev: 5'-TGTTGTCCTTGAGTCCTTGTGG-3' 
TGF-b Fw: 5'-CACTGATACGCCTGAGTGGC-3' Rev: 5'-TGCTGTCACAAGAGCAGTGAG-3' 
SAA1 Fw: 5'-CATTTGTTCACGAGGCTTTCC-3' Rev: 5'-GTTTTTCCAGTTAGCTTCCTTCATGT-3' 
SAA3 Fw: 5'-CGCAGCACGAGCAGGAT-3' Rev: 5'-CCAGGATCAAGATGCAAAGAATG-3' 
NOS2 Fw: 5'-ATGCTGCCACCTTGGAGTTCAC-3' Rev: 5'-GGCCACCCACCTCCAGTAGC-3' 






















Figure 2-S1. SFB-induced intestinal Th17 cells require MHCII expression in the 
periphery 
A. Cytokine expression in SI LP TCRβ+CD4+ cells in 10-week old SFB-monocolonized 
mice (SFB-mono) and germ-free (GF) controls or in SFB-negative conventionally-raised 
mice (SPF) before and 2 weeks after colonization with SFB 
B. Foxp3 expression in CD4 T cells isolated from the corresponding tissues of SFB-
positive WT and IAb-/- mice. Plots gated on TCRβ+CD4+ cells 
C-D. 5x106 sorted naïve CD4 T cells were transferred into WT and IAb-/- mice before or 
after colonization with SFB. IL-17 expression was examined in transferred cells in the SI 
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Figure 2-S2. SFB do not induce Th17 cell differentiation of non-SFB Tg T cells 
 A. IL-17 expression in SI LP CD4 T cells from SFB-positive OTII.B6 TCR Tg mice 
before or after stimulation with cognate antigen. OVA stimulation was performed by 
supplying 1% OVA protein in the drinking water ad libitum for 10-14 days.  Left, 
Vα2hiVβ5hi plots are gated through the gate shown in (B). Right, IL-17 expression in 
CD4 T cells outside the Vα2hiVβ5hi gate 
B. Expression of the Tg Vα2 and Vβ5 in CD4 T cells isolated from the corresponding 
tissues of SFB-positive OTII.B6 TCR Tg mice in the absence of OVA stimulation. Plots 
are gated on TCRβ+CD4+ cells. Vα2hiVβ5hi CD4 T cells include cells expressing the Tg 
TCR 
C. SI LP Th17 cells express alternative TCRs. Vα2 and Vβ5 expression in IL-17+ vs IL-
17- CD4 T cells in the SI LP of SFB-positive OVA.B6 Tg mice. All plots initially gated 
on TCRβ+CD4+ cells 
D. SI LP Th17 cells and lymph node CD4 T cells from OTII.B6 Il17GFP mice were 
labeled with CellTrace Violet (SI) or CFSE (LN) and stimulated in vitro with TCRα-
deficient splenocytes and OVA peptide or SFB lysates for 3 days. Plots gated on 
TCRβ+CD4+ cells. Top, GFP+ (IL-17+) CD4 T cells purified by FACS from SI LP. 
Middle, CD4 T cells were purified from MLNs by MACS using anti-CD4 magnetic 
beads. Bottom, Splenic CD4 T cells from TRP-1.RAG Tg mice were purified by MACS 
using anti-CD4 magnetic beads, labeled with CFSE, and stimulated in vitro with TRP-1 
peptide or SFB antigens for 3 days in the presence TCRα-deficient splenocytes 
E-F. SFB-free OTII.RAG or TRP-1.RAG TCR Tg mice were colonized with SFB-
containing microbiota from Taconic B6 mice. Colonization levels were confirmed by Q-
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PCR. 2-4 weeks later SFB-negative and SFB-positive mice were stimulated in vivo with 
the corresponding antigen 
E. OTII.RAG mice were stimulated with OVA by oral gavage at Day 1, 3 and 5 and by 
providing 1% OVA in the drinking water ad libitum. SI LP cells were isolated on Day 
12-14. RAG-sufficient SFB-positive control mouse is shown for comparison 
F. TRP-1.RAG mice were immunized i.p. with 50 µg TRP-1 peptide and 10 µg LPS on 
Day 1 and 7. Control mice received 10 µg LPS only. SI LP cells were isolated on Day 
12-14. 
 
Figure 2-S3. SFB do not induce Th17 cell differentiation of non-SFB Tg T cells 
A. 5x106 CD45.2+ CD4 T cells were purified from spleens and peripheral LNs of TRP-
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1.RAG mice by MACS using anti-CD4 magnetic beads and transferred into CD45.1+ 
recipients before or 12-14 days after colonization with SFB (Day 0). Recipient animas 
were immunized i.p. with 50 µg TRP-1 peptide and 10 µg LPS on Day 1 and 7. Control 
mice received transferred CD4 T cells and 10 µg LPS only. Th17 cell induction was 
examined in transferred Tg (CD45.2+) and endogenous WT (CD45.1+) cells 12-14 days 
after transfer 
B. 5x106 CD45.2+CD90.1+ WT CD4 T cells and 5x106 CD45.2+CD90.2+ TRP-1 Tg CD4 
T cells were purified from spleens and peripheral LNs of WT and TRP-1.RAG mice 
respectively, combined and co-transferred into WT CD45.1+CD90.2+ recipients before or 
12-14 days after colonization with SFB (Day 0). Recipient animas were immunized i.p. 
with 50 µg TRP-1 peptide and 10 µg LPS on Day 1 and 7. Th17 cell induction was 
examined in three different types of cells in the same animal 12 days after transfer. H - 
endogenous host WT cells (CD45.1+CD90.2+); W – transferred WT cells 
(CD45.2+CD90.1+); T - transferred Tg cells (CD45.2+CD90.2+) 
C. GFP and IL-17 expression in total SI LP cells (left and middle panel) and in CD4 T 
cells (right panel) isolated from the SI LP of heterozygous Il17GFP reporter mice 
D. Sorting scheme for isolation of purified SFB filaments. Feces from SFB-
monocolonized mice were processed as described in Methods and stained with the 
SYTO9 component of the Live/DeadRBacLightTM Bacterial Viability Kit (Life 
Technologies). SFB filaments were identified by SYTO9 staining and large size (SSC-W) 
and sorted on FACSAriaII (BD) to high purity. Representative FACS plots and photos 
show the presence of mostly large SFB filaments and absence of small bacterial cells or 
host/fecal debris after sorting. PBS only, negative control of sterile PBS used to 
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resuspend the SFB sample after sorting. Arrowheads, SFB filaments of variable size in 
the sample used for sorting 
E. GFP+ (Th17) and GFP- (non-Th17) TCRb+CD4+ cells were purified by FACS from SI 
LP of SFB-positive Il17GFP reporter mice and stimulated in vitro with SFB lysates 
prepared after density gradient (SFB Gradient) or from SFB filaments purified by cell 
sorting on panel C (SFB Sorted) 
F. GFP+ (Th17) and GFP- (non-Th17) TCRb+CD4+ cells were purified by FACS from SI 
LP of SFB-positive (SFB+) or SFB-negative (No SFB) RorcGFP reporter mice and 
stimulated in vitro with SFB antigens 
G. IL-17 expression in proliferated (CellTracelo) GFP+ and GFP- SI LP CD4 T cells from 
Figure 2F stimulated in vitro with SFB antigens for 3 days. Plots are gated on live, 
proliferated T cells 
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Figure 2-S4. SFB induce Th17 cells with diverse Vβ  utilization 
A. SFB-negative Jackson B6 mice (Jax) were colonized with SFB by oral gavage with 
SFB-containing Taconic feces (Jax + SFB) and IL-17 induction in different Vb families 
was examined by flow cytometry 14 days after colonization. Plots represent percentage 
of IL-17+ cells in the TCRβ+CD4+Vb+ subset for the corresponding Vb.  
B.  Vb and IL-17 expression in SI LP CD4 T cells of germ-free and SFB-monocolonized 
C57BL/6 mice. Plots represent percentage of IL-17+ cells in the TCRβ+CD4+Vb+ subset 
for the corresponding Vb. ND, not determined 
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Figure 2-S5. Effects of SFB colonization in DCΔMHCII mice 
A. CD11c+ cell subsets in the SI LP of DCΔMHCII and control littermates. Bar plots 
represent total numbers or percentage of the corresponding subset in the CD11c+ gate  
B. MHCII expression in APC subsets from SI LP of WT and DCΔMHCII mice 
C. Relative expression of SFB-induced genes in terminal ileum of DCΔMHCII and control 
littermates (WT) before and after colonization with SFB determined by RT-PCR. ns, not 
significant 
D. Th1 cells in the SI LP of DCΔMHCII and control littermates before and after SFB 
colonization 
E. Foxp3 expression in CD4 T cells from the indicated organs. SFB-negative DCΔMHCII 
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mice and control littermates were colonized with SFB by oral gavage and Foxp3+ Tregs 
analyzed 12-14 days later. Plots represent the percentage of Foxp3+ cells in the 
TCRb+CD4+ population. p values compare DCΔMHCII mice to corresponding WT 
littermate group 
F. SFB levels in fecal pellets from DCΔMHCII and control littermates 3 weeks after SFB 
colonization 
G. SFB attachment and MHCII expression in terminal ileum epithelial cells in WT and 
DCΔMHCII mice colonized with SFB. Note lack of MHCII expression in LP of the 
DCΔMHCII littermate. Blue, DNA; Green, MHCII; Red, Actin 
H. SFB-negative Cµ-deficient and WT control mice were obtained from Jackson 
Laboratory. The mice were co-housed for a week and colonized with SFB by gavage with 
fecal homogenates from SFB-monocolonized mice. Control animals were gavaged with 
fecal homogenates from SFB-negative mice. SFB absence or colonization was confirmed 




Figure 2-S6. SFB-mediated Th17 cell responses in IECΔMHCII and ILC3ΔMHCII mice 
A. MHCII expression on cell subsets from SI LP of WT and IECΔMHCII mice 
B. SFB levels in feces of IECΔMHCII and control littermates assessed by 16S rRNA gene 
RT-PCR 
C. MHCII expression in terminal ileum of IECΔMHCII mice and WT littermates 2 weeks 
after colonization with SFB. MHCII expression is observed only in the LP in IECΔMHCII 
mice. Arrows point to SFB filaments, attaching to IECs 
D. MHCII expression on RORgt+c-kit+NKp46+ (R2) and RORgt+c-kit-NKp46- (R3) ILCs 
in WT and ILC3ΔMHCII mice. R2 and R3 gates as shown on Figure 5D 
E. MHCII expression on cell subsets from SI LP of WT and ILC3ΔMHCII mice 
F. Normal colonic histology and lack of intestinal inflammation in ILC3ΔMHCII mice 
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G. Foxp3+ Tregs in SI LP of ILC3ΔMHCII mice and control littermates before and after 
colonization with SFB 
H. WT SFB-negative mice were gavaged twice with fecal homogenates from SFB-
negative ILC3ΔMHCII mice (with high levels of SI LP Th17 cells). IFNg and IL-17 
expression in SI LP CD4 T cells was examined 3 weeks after gavage 
I. CD4 T cells were purified by cell sorting from SI LP of SFB-positive and SFB-
negative WT and ILC3ΔMHCII mice and incubated in vitro with SFB or other bacterial 
lysates as in Figure 2. T cell proliferation was examined on Day 3 of culture 
J-K. SFB colonization in feces and attachment to terminal ileum villi in ILC3ΔMHCII mice 
and control littermates 
L. Total numbers of Vb14+IL-17+ Th17 cells in ILC3ΔMHCII mice and control littermates 










Figure 2-S7. SFB priming of CD4 T cells in gut mucosa 
107 MACS-purified CD4 T cells from spleens and LNs of CD45.2+ Il17GFP mice were 
labeled with CellTrace Violet proliferation dye and adoptively transferred into WT 
CD45.1+ mice before or 12 days after SFB colonization. T cell proliferation (dye 
dilution) and Th17 cell induction (GFP expression) was examined at different time points 
in small intestinal lamina propria (SI LP) and Peyer’s Patches (PP). Very low 




Table 2-S1. Diverse TCR repertoire of SFB-recognizing hybridomas 
CDR3 regions and Vb utilization in TCRb chains, sequenced from 15 SFB-recognizing 
hybridomas. Clone numbers correspond to clone numbers on Figure 2-3B. The sequences 
are arranged by Vb usage (right-most column). The two identical sequences are 
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Generation of different CD4 T cell responses to commensal and pathogenic bacteria is 
crucial for maintaining healthy gut environment, but the associated cellular mechanisms 
are poorly understood. Dendritic cells (DCs) and macrophages (Mfs) integrate microbial 
signals and direct adaptive immunity. Although the role of DCs in initiating T cell 
responses is well appreciated, how Mfs contribute to the generation of CD4 T cell 
responses to intestinal microbes is unclear. Th17 cells are critical for mucosal immune 
protection and at steady state are induced by commensal bacteria, such as segmented 
filamentous bacteria (SFB). Here, we examined the roles of mucosal DCs and Mfs in 
Th17 induction by SFB in vivo. We show that Mfs, and not conventional CD103+ DCs, 
are essential for generation of SFB-specific Th17 responses. Thus, Mfs drive mucosal T 














We recently showed that commensal Th17 cell induction is mediated by the antigen-
presenting function of CD11c+MHCII+ MNPs in the small intestinal (SI) LP 202. To 
characterize the role of different MNP subsets in this process we examined Th17 cell 
induction by SFB following genetic ablation. Four major CD11c+MHCII+ MNP subsets 
were followed throughout this study using the gating strategies in Figure 3-1A and 3-
S1A. Conventional CD103+ LP DCs consist of gut-specific CD103+CD11b+ DCs (DP 
DCs) controlled by the transcription factors Notch2 and IRF4 56,61,86 and CD103+CD11b- 
DCs (CD103 SP DCs) that require BATF3 and IRF8 for their development 303. The 
remaining CD103-CD11b+ MNPs express the chemokine receptor CX3CR1 and consist 
predominantly of intestinal Mfs, which were identified based on expression of CD64 and 
F4/80 304, and a smaller population of CD64-F4/80- MNPs, that express intermediate 
levels of the monocyte/Mf marker CX3CR1, but also express the DC markers CD24 and 
CD26 (Figure 3-S1B). Although CD103-CD11b+CD64-CD24+ cells may represent a 
phenotypically and developmentally heterogeneous population 305-307, we refer to them 
here as CD11b single positive DCs (CD11b SP DCs).  
 
A. DP DCs are dispensable for Th17 cell induction 
DP DCs have been shown to promote Th17 cell differentiation in vitro 307. In addition, 
we and others have shown a decrease in LP Th17 cell numbers in mice with genetic 
deficiency of DP DCs, suggesting a role for this MNP subset in vivo 56,61,86,308. However, 
the specific role of DP DCs in microbiota-mediated induction of Th17 cells has not been 
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examined. To this end, we colonized DP DC-deficient mice and wildtype (WT) 
littermates, with SFB and examined Th17 cell induction and induction of SFB-specific 
CD4 T cells in the SI LP. 
 Langerin-DTA mice 309 express diphtheria toxin (DT) under transcriptional 
control of the human Langerin promoter resulting in selective ablation of epidermal 
Langerhans cells as well as DP DCs in the SI LP (Figure 3-1A,B, Table 3-S1 and 308). 
Migratory DP DCs were also absent in MLN of Langerin-DTA mice (Figure 3-1C,D). 
Colonization of WT littermates with SFB led to induction of RORgt+ and IL-17+ (Th17) 
CD4 T cells in the SI LP (Figure 3-1E-J). In addition, SFB colonization resulted in 
induction of SFB-specific CD4 T cells as demonstrated by the enrichment of Vb14+ Th17 
cells 202,281 (Figure 3-1G,J) and by the response of purified SI LP CD4 T cells to SFB 
antigens in vitro (Figure 3-1K,L). When Langerin-DTA mice were colonized with SFB, 
Th17 cells in the LP expanded similarly to those in WT littermates (Figure 3-1E-J). 
Moreover, significant induction of SFB-specific Vb14+ Th17 cells and response of LP 
CD4 T cells to SFB antigens in vitro were evident (Figure 3-1J-L). These results 
demonstrate that DP DCs are dispensable for both T cell priming and Th17 cell 
differentiation following SFB colonization.  
 We obtained similar results using another model of DP DC depletion. DP DC 
development depends on Notch2 and conditional deletion of Notch2 in CD11c+ cells 
leads to significant loss of DP DCs 86. Similarly to Langerin-DTA mice, loss of DP DCs 




B. CD103 DCs are dispensable for Th17 cell induction by SFB 
CD103 SP DCs are capable of migrating to the MLN, share a developmental pathway 
with CD8a+ splenic DC, and are proficient in cross-presentation 303,305,310,311. Whether 
they play a non-redundant role in commensal CD4 Th17 cell responses is not known. To 
address their role in SFB-induced Th17 cell differentiation, we colonized SFB-negative 
BATF3-deficient mice and heterozygous littermates with SFB and compared Th17 cell 
induction and induction of SFB-specific CD4 T cells (Figure 3-S3). As previously 
reported 303, BATF3-deficient mice lacked CD103 SP DCs in LP and MLN (Figure 3-
S3A-D). Nevertheless, Th17 cell induction after SFB colonization was unaffected in 
these animals. Similarly, induction of SFB-specific CD4 T cells and response to SFB 
antigens were similar to littermate controls (Figure 3-S3E-M). Therefore, CD103 SP DCs 
are not required for commensal-induced Th17 cell priming and differentiation. 
 The two subsets of CD103+ DCs represent the main conventional DC subsets in 
the LP and have both been shown to migrate to MLN and prime CD4 T cell responses 
51,52,305,312. To account for potential redundant functions of these subsets in Th17 
responses to SFB, we crossed Langerin-DTA mice and BATF3-deficient mice (Figure 3-
2). The resulting double-knockout (DKO) mice lacked all CD103 DC subsets in both SI 
LP and MLN (Figure 3-2A-D and Table 3-S1). Despite the absence of virtually all 
CD103 DCs, colonization of DKO and littermate control mice with SFB led to a similar 
induction of RORgt+ and IL-17+ CD4 T cells in the SI LP (Figure 3-2E-J). In addition, 
there was a significant induction of Vb14+RORgt+ and Vb14+IL-17+ SFB-specific CD4 T 
cells in the DKO small intestine (Figure 3-2E,G,H,J), and isolated SI LP CD4 T cells 
from DKO mice responded to SFB antigens in in vitro proliferation assays similarly to 
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WT CD4 T cells (Figure 3-2K,L). We generated another model of CD103 DC deficiency 
by crossing BATF3-deficient mice and CD11c-Cre/Notch2-flox mice. These animals also 
lacked both CD103+ DC subsets and showed normal Th17 cell responses to SFB (data 
not shown). These results demonstrate that LP CD103 DCs are dispensable for priming of 
SFB-specific CD4 T cells and Th17 cell induction in response to SFB. 
 
C. Conventional DCs are dispensable for commensal Th17 cell induction at steady 
state 
Conventional intestinal DCs depend on the DC-specific growth factor Flt3L 51,306,313. To 
determine if conventional DCs in general play a role in generation of SFB-induced Th17 
cells, we examined Th17 cell induction in Flt3L-deficient mice. Similarly to CD103+ 
DCs, CD11b+CD103- DCs have been shown to derive from pre-DC precursors, be 
dependent on Flt3L and are, significantly decreased in Flt3L-deficient mice 306.  We 
established SFB-negative Flt3L-deficient mice and compared Th17 cell induction 
following SFB colonization. CD103+ DC were almost absent from the SI LP in these 
animals (>90% reduction, compared to heterozygous littermates). Flt3L-deficient mice 
also had significantly diminished CD11b SP DCs, in agreement with previous studies 306 
(Figure 3-3A,B and Table 3-S1). All subsets of migratory DCs were also severely 
reduced in MLN (Figure 3-3C). In contrast, the total number of CD64+ Mfs in the SI LP 
was similar between control littermates and Flt3L-deficient mice (Figure 3-3A,B). 
Surprisingly, despite the severe defect in DC numbers, as well as possible defects in 
lymphocyte development in Flt3L-deficient animals, SFB still induced normal levels of 
Th17 cells (Figure 3-3D-I). In addition, priming and generation of SFB-specific CD4 T 
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cells was virtually unperturbed, as was the generation of antigen-specific Th17 cells 
(Figure 3-3I-K). 
 Based on the combined data in Figures 1-3, we conclude that conventional gut 
CD103+ DCs and Flt3L-dependent CD103- DCs are not required for the acquisition and 
presentation of SFB antigens, priming of SFB-specific T cells and induction of Th17 cells 
in the SI LP. 
 
D. Nongenotoxic depletion of intestinal monocyte-derived cells prevents SFB-
specific Th17 cell responses 
To directly examine the role of intestinal Mfs we utilized a transient depletion system. 
Although only a fraction of LP Mfs express high levels of CCR2 (Figure 3-S6A), steady 
state intestinal Mfs are derived from CCR2+ blood monocytes 51,52,314 and can be 
depleted in CCR2-DTR mice following diphtheria toxin (DT) treatment 235,315. A single 
DT injection led to a near complete ablation of intestinal Mfs beginning at 24h and 
lasting until at least 72 hours post treatment (Figure 3-S4D). Depletion of Mfs could be 
maintained with DT injections every 2 days for at least 12 days (Figure 3-4A). DT 
treatment did not affect CD103 DP DCs, which were still present in the LP and in the 
migratory DC population in MLN in treated CCR2-DTR mice (Figure 3-4B-E). In 
addition, few LP CD4 T cells and SFB-induced Th17 cells expressed CCR2 and DT 
treatment did not affect Th17 cell numbers or the presence of SFB-specific Th17 cells in 
SFB-positive CCR2-DTR mice (Figure 3-S4A-C). To assess the role of monocyte-
derived Mfs, SFB-negative CCR2-DTR mice and littermate controls were treated with 
DT every 48 hours for 10 days. The mice were colonized with SFB on Day 2 and Th17 
100 
induction was analyzed 8 days later (Figure 3-4A). SFB colonization was similar between 
the two groups (Figure 3-S4E). SFB induced high levels of Th17 cells in control animals 
with induction of Vb14+ SFB-specific Th17 cells and proliferation of SI LP CD4 T cells 
in response to SFB antigens (Figure 3-4F-J and Figure 3-S4G-I). In contrast, SFB 
colonization did not lead to Th17 cell induction in DT treated CCR2-DTR mice (Figure 
3-4F,G and Figure 3-S4G,H). Moreover, SI LP CD4 T cells from CCR2-DTR mice 
depleted of Mfs did not respond to SFB antigens in vitro and did not contain Vb14+ SFB-
specific Th17 cells (Figure 3-4F,H,I,J and Figure 3-S4G,I). These results suggest that 
monocyte-derived cells are required for induction of SFB-specific Th17 cell responses.  
 
E. Transfer of exogenous monocytes rescues defects in Th17 cell induction following 
Mf depletion 
DT treatment in CCR2-DTR mice resulted in depletion of all CCR2 monocyte-derived 
subsets. However, we found that prolonged treatment also affected certain DC subsets. 
Prolonged DT treatment led to a loss of CD103 SP DCs (Figure 3-4B,C). In addition, DT 
treatment led to depletion of a subset of CD11b SP DCs that express CCR2 306 (Figure 3-
S6A). However, as shown earlier, CD103 SP DCs and Flt3L-dependent CCR2+ CD11b 
SP DCs 306 are dispensable for SFB-mediated Th17 cell induction (Figure 3-3 and 3-S3). 
Prolonged DT treatment also resulted in a decrease in total migratory DCs in the MLN, 
although the numbers of MLN CD103+CD11b+ DCs (DP DCs) were normal (Figure 3-
4D,E and 3-S4F). 
To better investigate whether the defect in Th17 cell induction is due to the lack 
of monocyte-derived cells, and to further exclude the possibility that DT treatment affects 
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CD4 T cells or other non-monocyte derived populations, we performed gain-of-function 
experiments. We isolated Lin-Ly6C+CCR2+ monocytes to high purity from bone marrow 
(BM) of CD45.1 C57BL/6 congenic mice. Lineage markers included CD3, B220, NK1.1, 
CD11c, and c-Kit, to eliminate dendritic cell progenitors and hematopoietic stem cells 
240. CD45.2 CCR2-DTR mice were treated with DT every 60 hours to maintain depletion 
of endogenous monocytes. After the initial DT injection, one group of CCR2-DTR mice 
received 5-10 x 106 CD45.1+ BM monocytes. Control mice received DT, but did not 
receive any recipient cells. Following the monocyte graft, mice were colonized with SFB 
and Th17 cell induction was assessed 10 days later (Figure 3-5A). In agreement with 
previous studies 52, transferred monocytes exclusively reconstituted the CD64 Mf 
compartment and donor-derived CD45.1 cells were not detectable in any of the other 
MNP subsets, neither in SI LP nor in MLN (Figure 3-5B,C and Figure 3-S5C,D). 
Similarly to previous experiments, SFB colonization did not induce SFB-specific Th17 
cells in control CCR2-DTR mice without transfer. In contrast, transfer of monocytes and 
recovery of the LP Mf population, resulted in recovery of SFB-specific Th17 cell 
responses, including the presence of CD4+RORgt+ cells, CD4+IL-17+ cells in the LP, and 
response of LP CD4 T cells to SFB antigens in vitro (Figure 3-5E-L). Interestingly, 
monocyte transfer also led to partial increase in endogenous CD45.2+ (host-derived) DCs, 
especially in the migratory DC fraction of MLN (Figure 3-5D and 3-S5A,B), although it 
did not significantly increase the number of CD103 SP DCs, underscoring the fact that 
this subset is dispensable for Th17 cell induction. These results demonstrate that 
monocyte-derived LP Mfs are essential for initiation and maintenance of SFB-specific 
Th17 cell responses, possibly with help from migratory DCs.  
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F. Specific depletion of CD64 Mfs leads to loss of SFB-mediated Th17 cell induction 
To further confirm the role of CD64 Mfs, we sought to implement an independent 
depletion model. In contrast to DCs, intestinal Mf development and maintenance depends 
on CSF1R (also known as M-CSFR) 51. Injection of a CSF1R-blocking antibody (clone 
AFS98) can specifically deplete intestinal Mfs in a dose-dependent manner without 
affecting resident DC subsets 18,277,313. We therefore treated WT C57BL/6 mice with a 
high dose of AFS98, or control IgG, prior to SFB colonization. As shown in Figure 3-6, 
AFS98 treatment led to a significant and specific depletion of intestinal Mfs. The average 
depletion was ~95% in the CD64 Mf fraction. In contrast, LP DC subsets, including 
CD103 SP DCs, DP DCs, and CD11b SP DCs were not affected by this treatment (Figure 
3-6A,B and 3-S6B and Table 3-S1). Moreover, we did not detect any noticeable defects 
in the number and phenotype of migratory DC subsets in the MLN (Figure 3-6D,E). SFB 
colonization led to Th17 cell induction in mice treated with control IgG 8 days after 
introduction of the bacteria, which included induction of CD4+RORgt+ and CD4+IL-17+ 
cells and induction of SFB-specific Th17 cells as demonstrated by the induction of 
Vb14+RORgt+ and Vb14+IL-17+ cells (Figure 3-6F-K). In contrast, in mice treated with 
AFS98, RORgt+ and IL-17+ Th17 cells, as well as SFB-specific Th17 cells were 
significantly reduced and were similar to the levels in SFB-negative controls (Figure 3-
6F-K). These results demonstrate that intestinal CD64 Mfs are essential for initiation of 
antigen-specific Th17 cell responses to an intestinal commensal. 
Our data demonstrate a crucial in vivo function of intestinal Mfs in controlling 
effector T cell-homeostasis to luminal bacteria. Identification of the exact mechanisms of 
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antigen acquisition and the location of T cell priming will be important future questions 
to address. Regardless of the details, this mechanism must be distinct from conventional 
sampling of luminal antigens by DCs at steady state or by the DC/Mf-mediated acute 
immune response to invasive pathogens. Because of the specific nature of the interaction 
of SFB with the host, we propose that this pathway may represent a more general 
mechanism for inducing localized effector Th17 cell responses to mucosa-associated non-








Langerin-DTA, BATF3-/-, Notch2F/F, CX3CR1-GFP and CD11c-Cre mice were obtained 
from the Jackson Laboratory. Flt3l-/- mice were obtained from Taconic farms and derived 
SFB-free by antibiotic treatment of a founder breeding pair, followed by fecal 
transplantation of Jackson (SFB-negative) microbiota. CCR2-DTR and CCR2-GFP mice 
have been previously described 315. CCR2-DTR mice were re-derived by embryo transfer 
and kept SFB-negative in our colony. All mice were bred and housed under specific 
pathogen-free conditions at Columbia University Medical Center under IACUC approved 
guidelines. To control for microbiota and cage effects, all experiments were performed 
with littermate control animals housed in the same cage. 
 
SFB colonization and Th17 cell induction 
All mice, regardless of origin, were screened at multiple points for the presence and 
levels of SFB by quantitative PCR 316. Bacterial genomic DNA isolation from fecal 
pellets and quantitative PCR for the SFB 16S rRNA gene were performed as previously 
described 147,316. SFB colonization was performed by oral gavage with SFB-containing 
fecal pellets. To control for SFB levels in the feces used for gavage, as well as for other 
constituents of the microbiota between experiments, all gavages were performed with 
frozen stocks from a single batch of feces obtained from 10 SFB-positive Taconic B6 
mice. Control mice were gavaged with fecal pellets from SFB-negative littermates in our 
colony or with PBS. SFB colonization levels were confirmed by quantitative PCR and 
normalized to levels of total bacteria (UNI). SI LP Th17 cell induction was assessed 8-10 
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days after gavage unless otherwise noted. 
 
Lamina propria cell isolation and in vitro co-culture experiments 
Lamina propria (LP) lymphocytes, intracellular cytokine staining, and RORgt staining 
were performed as previously described 147. LP CD4+ T cells were purified by positive 
selection using anti-CD4 magnetic microbeads and MACS columns (Miltenyi Biotec). 3-
5 x 104 CD4 T cells were co-cultured in 96-well U-bottom plates with 5 x 104 MACS 
purified splenic CD11c+ cells as APCs in the presence or absence of autoclaved bacterial 
lysates prepared from feces of SFB-monocolonized mice (SFB) or SFB-negative Jackson 
C57BL/6 mice (Jax) as previously described 202,316. T cell proliferation was assessed 72 
hours later by counting the number of live proliferated CD4 T cells.  
 
DT treatment for ablation of intestinal Mfs 
SFB-negative CCR2-DTR mice and littermate controls were treated with 20 ng/g 
diphtheria toxin (DT) i.p. on Day 0 and every 48 or 60 hours after that for the duration of 
the experiment (a total of 6 or 5 injections respectively). On Day 2 some mice were 
gavaged twice with SFB-containing fecal homogenates. Th17 cell induction was 
examined on Day 10. 
 
Adoptive transfers 
SFB-negative CD45.2 CCR2-DTR mice were treated with DT on Day 0 and every 60 
hours after that (total of 5 injections). On Day 1.5 some of the mice received 5-10 x 106 
Lin-GFP+ bone marrow monocytes, purified from congenic CD45.1 CCR2-GFP mice 315 
106 
or Lin-Ly6Chi bone marrow monocytes from CD45.1 C57BL/6 mice by cell sorting. 
Transfer of a large number of BM monocytes was required to reconstitute the LP Mf 
compartment in monocyte-depleted CCR2-DTR mice to significant levels. Recipient 
mice were gavaged with SFB on Day 2 and DC subsets and Th17 cell induction were 
examined on Day 12. The Lin(eage) cocktail included B220, CD3, NK1.1, CD11c, and 
CD117 (c-Kit). Sorting was performed on a FACS Aria II (BD). 
 
Macrophage depletion 
For macrophage depletion, four days prior to SFB colonization, SFB-negative C57BL/6 
mice were injected intra-peritoneally with 150 ug/g of body weight of CSF1R blocking 
antibody (clone AFS98 317), purified from a hybridoma as described earlier 318  
 
Cell numbers and statistics 
To compensate for differences in yield between experiments, in some figures numbers of 
lamina propria and mesenteric lymph node mononuclear cell subsets are represented as 
percentage of total live single cells (gate R1 in Figure S1B). Significance was determined 
by the Student’s unpaired two-tailed t test unless otherwise noted. P values were 
represented on figures as follows: ns, p ≥ 0.05, * p < 0.05, ** p < 0.01, *** p < 0.005, 
**** p < 0.001, ***** p < 0.0005, ****** p < 0.0001. Error bars on all figures represent 
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Figure 3-1. CD103+CD11b+ (DP) DCs are dispensable for commensal Th17 cell 
induction. (A,B) CD11c+MHCII+ MNP subsets in SI LP of Langerin-DTA mice and 
control wildtype littermates (WT LM). (A left) FACS plots gated on CD11c+MHCII+ 
cells. A (right) Distribution of CD64 Mfs and CD11b SP DCs within the CD103-CD11b+ 
gate. Numbers represent percentage of cells in the corresponding gate. (B) Total number 
of cells in individual MNP subsets as defined in (A). (C,D) Total cell numbers and cell 
numbers in MNP subsets in the migratory DC fraction of mesenteric lymph nodes 
(MLN). Plots in (C) are gated on Lin-CD11cloMHCIIhi migratory DC. (E-G) Induction of 
RORgt+ Th17 cells by SFB in small intestinal (SI) LP. Plots gated on TCRb+CD4+ cells. 
(H-J) Induction of IL-17+ Th17 cells by SFB in SI LP. Plots gated on TCRb+CD4+ cells. 
(K,L) Response of purified SI LP CD4 T cells to SFB antigens or control bacterial 
antigens (Jax antigens) prepared as described in Methods. Open circles in bar graphs in 






Figure 3-2. CD103+ DCs are dispensable for commensal Th17 cell induction. (A,B) 
CD11c+MHCII+ MNP subsets in SI LP of Langerin-DTA X BATF3-/- (DKO) mice and 
control littermates. (A left) FACS plots gated on CD11c+MHCII+ cells. Numbers 
represent percentage of cells in the corresponding gate. (B) total number of cells in 
individual MNP subsets. (C,D) Total cell numbers and cell numbers in MNP subsets in 
the migratory DC fraction of mesenteric lympn nodes (MLN). (E-G) Induction of 
RORgt+ Th17 cells by SFB in small intestinal (SI) LP. Plots gated on TCRb+CD4+ cells. 
(H-J) Induction of IL-17+ Th17 cells by SFB in SI LP. Plots gated on TCRb+CD4+ cells. 
(K) Response to SFB antigens of purified SI LP CD4 T cells from DKO and control 
littermates. SI LP CD4 T cells were isolated before (No SFB) and after (+SFB) 
colonization with SFB and incubated with CD11c+ splenic DCs for 72 hours in the 
presence of SFB antigens. (L) Proliferation of purified SI LP CD4 T cells in response to 
SFB antigens. LP CD4 T cells were isolated and cultured as in K in the presence of SFB 
antigens as described in Methods. Open circles in bar graphs in all panels represent data 





Figure 3-3. Conventional DCs are dispensable for commensal Th17 cell induction. 
(A,B) CD11c+MHCII+ MNP subsets in SI LP of Flt3l-/- mice and control heterozygous 
littermates (Flt3l+/-). (A left) FACS plots gated on CD11c+MHCII+ cells. Numbers 
represent percentage of cells in the corresponding gate. (B) total number of cells in 
individual MNP subsets. (C) Total cell numbers and cell numbers in MNP subsets in the 
migratory DC fraction of mesenteric lymph nodes (MLN). (D-F) Induction of RORgt+ 
Th17 cells by SFB in SI LP. Plots gated on TCRb+CD4+ cells. (G-I) Induction of IL-17+ 
Th17 cells by SFB in SI LP. Plots gated on TCRb+CD4+ cells. (J,K) Response of purified 
SI LP CD4 T cells to SFB antigens and antigens isolated from SFB-negative feces (Jax 
antigens). CD4 T cells were isolated from the SI LP of SFB-colonized Flt3l+/- or Flt3l-/- 
mice and assessed for antigen reactivity as described in Methods. Open circles in bar 
graphs represent data from individual animals. Data combined from two experiments 






Figure 3-4. Intestinal Mfs are required for mucosal Th17 cell induction. (A) 
Experimental design. CCR2-DTR mice and WT littermates were treated with DT every 
48h as described in Methods. SFB colonization occurred on Day 3 and Th17 cells were 
examined on Day 12. (B,C) CD11c+MHCII+ MNP subsets in SI LP of CCR2-DTR mice 
and control littermates (WT LM) treated with DT for 12 days. (B left) FACS plots gated 
on CD11c+MHCII+ cells. Numbers represent percentage of cells in the corresponding 
gate. (C) Number of cells in individual MNP subsets represented as percentage of total 
live SI LP cells (gate R1 in Figure S1B). (D,E) Cell numbers represented as percentage of 
total live single cells (D) and MNP subsets in the migratory DC fraction of mesenteric 
lymph nodes (MLN). Plots in (E) are gated on Lin-CD11cloMHCIIhi migratory DCs. (F-
H) Induction of RORgt+ Th17 cells by SFB in SI LP. Plots gated on TCRb+CD4+ cells. 
(I) Response to SFB antigens of purified SI LP CD4 T cells from DT-treated CCR2-DTR 
and control littermates. (J) Proliferation of purified SI LP CD4 T cells. LP CD4 T cells 
were isolated and cultured as in (I) in the presence of SFB antigens or control bacterial 
antigens (Jax antigens) as described in Methods. Open circles in bar graphs represent data 







Figure 3-5. Exogenous monocytes recover Th17 cell induction in Mf-depleted mice  
 
(A) Experimental design. DT-treated CCR2-DTR mice were reconstituted on Day 1.5 
with 5-10 X 106 Lin-Ly6Chi monocytes purified from bone marrow of CD45.1 congenic 
mice. (B) Reconstitution of CD64 Mfs in SI LP by transfer of BM monocytes (+Mono). 
(C) SI LP MNP subsets represented as percentage of total live single cells (D) Cell 
number of migratory DCs in MLN represented as percentage of total live single cells. (E-
G) Induction of RORgt+ Th17 cells by SFB in SI LP. Plots gated on TCRb+CD4+ cells. 
(H-J) Induction of IL-17+ Th17 cells by SFB in SI LP. Plots gated on TCRb+CD4+ cells. 
(K,L) Response of purified SI LP CD4 T cells to SFB antigens. Open circles represent 






Figure 3-6. Treatment with CSF1R-blocking antibody impedes Th17 responses to 
SFB 
(A,B) MNP subsets in the SI LP of C57BL/6 mice treated with high dose of anti-CSF1R 
monoclonal antibody (AFS98) or control IgG four days before SFB colonization. (C) 
SFB levels in feces of AFS98 and control IgG treated mice normalized to total bacterial 
DNA (UNI). (D,E) Total cell numbers and cell numbers in MNP subsets in the migratory 
DC fraction of mesenteric lymph nodes (MLN). (F-H) RORgt+ Th17 cells in SI LP 8 
days after SFB gavage. Plots gated on TCRb+CD4+ cells. (I-K) IL-17+ Th17 cells in SI 








Figure 3-7. Central role of intestinal Mfs in generation of commensal-induced Th17 
cells 
Intestinal Mfs acquire antigens from epithelium-associated SFB and initiate SFB-specific 
Th17 cell responses. CD103+ DCs are dispensable for the induction of Th17 cells. 
Intestinal Mfs may participate in the Th17 cell differentiation stage locally in the LP or 
collaborate with CX3CR1+ DCs for antigen transfer into MLN or Th17 cell 








Figure 3-S1. Phenotype of mononuclear phagocyte subsets 
(A) Gating scheme used to identify intestinal MNP subsets. Lamina propria mononuclear 
cells were isolated from small intestines of WT and CX3CR1-GFP mice. Numbers reflect 
percentage of cells within the corresponding gate. The gates identifying the four 
mononuclear phagocyte subsets are color-coded.  
(B) Expression of surface markers by small intestinal lamina propria mononuclear 
phagocyte subsets (black line) identified as in (A), compared to a negative cell subset in 





Figure 3-S2. DP DCs are not required for SFB-induced Th17 cell responses 
(A) Defect in DP DC development in CD11c-Cre/Notch2-flox mice (CD11cΔNotch2 mice) 
(B) SFB colonization induces normal levels of Th17 cells in CD11cΔNotch2 mice. Plots 






Figure 3-S3. CD103+CD11b- (CD103 SP) DCs are dispensable for commensal Th17 
cell induction  
(A,B) CD11c+MHCII+ MNP subsets in SI LP of BATF3-/- mice and control heterozygous 
littermates. (A) FACS plots gated on CD11c+MHCII+ cells. Numbers represent 
percentage of cells in the corresponding gate. (B) total number of cells in individual MNP 
subsets represented as percentage of total live single cells 
(C,D) Total number and individual DC subsets in the migratory fraction from MLN of 
BATF3-/- mice and control heterozygous littermates. Plots gated as in Figure S2. Cell 
numbers in (D) are presented as percentage of total live single cells 
(E-G) Induction of RORgt+ Th17 cells by SFB in SI LP. Plots gated on TCRb+CD4+ cells 
(H-K) Induction of IL-17+ Th17 cells by SFB in SI LP. Plots gated on TCRb+CD4+ cells.  
(L) Response to SFB antigens of purified SI LP CD4 T cells from BATF3-/- and 
BATF3+/- littermates. SI LP CD4 T cells were isolated before (No SFB) and after 
(+SFB) colonization with SFB and incubated with CD11c+ splenic DCs for 72 hours in 
the presence of SFB antigens.  
(M) Proliferation of purified SI LP CD4 T cells in response to various antigens. LP CD4 
T cells were isolated and cultured as in F in the presence of SFB or control SFB-negative 
bacterial antigens (Jax antigens) as described in Methods. Open circles in bar graphs 







Figure 3-S4. Cell subsets in CCR2-DTR mice following DT treatment  
(A) CCR2 expression on total CD4 T cells in WT and CCR2-DTR mice treated with DT 
for 12 days. Plots gated on TCRb+CD4+ cells 
(B) CCR2 expression on Th17 cells in WT and CCR2-DTR mice treated with DT for 12 
days. Plots gated on TCRb+CD4+IL-17+ cells 
(C) Effects of DT treatment on Th17 cells in CCR2-DTR mice. WT and CCR2-DTR 
mice were colonized with SFB for several weeks to induce Th17 cell differentiation and 
then treated with DT every 48 hours for 12 days. DT treatment led to ablation of CD64 
Mfs in CCR2-DTR mice (not shown), but did not lead to decrease in the numbers of 
SFB-induced Th17 cells compared to WT mice 
(D) Kinetics of Mf depletion in CCR2-DTR mice. CCR2-DTR and WT mice received a 
single injection of DT and SI LP MNP subsets were examined 24 or 72 hours later. Plots 
gated on CD11c+MHCII+ cells. 
(E-I) CCR2-DTR and WT littermates (LM) were treated with DT and colonized with 
SFB as described in Figure 4A 
(E) SFB levels on Day 12 assessed by Q-PCR for SFB 16S rRNA gene normalized to 
total 16S rRNA (UNI) 
(F) DC subsets in the migratory fraction of MLN from WT and CCR2-DTR mice. Cell 
numbers are presented as percentage of total live single cells 






Figure 3-S5. Recovery of intestinal Mfs by monocyte transfer 
CCR2-DTR and WT littermates (LM) were treated with DT and colonized with SFB as 
described in Figure 5A. Shortly before SFB colonization some mice received an adoptive 
transfer of 5-10 X 106 bone marrow monocytes (+ Mono) from CD45.1+ congenic mice 
(Figure 5A) 
(A,B) DC subsets in the migratory DC fraction of MLN from DT-treated SFB-colonized 
WT and CCR2-DTR mice with and without transfer of 5-10 X 106 bone marrow 
monocytes (+ Mono)  
(C) MNP subsets in small intestinal LP of CCR2-DTR mice with and without monocyte 
transfer. MNP plots (far left) are gated on all CD11c+MHCII+ cells. Donor-derived cells 
were identified as CD45.1+ and were found only in the CD64+CD24- Mf fraction, but not 
in the CD64-CD24+ DC fraction (right plots) 
(D) Donor-derived cells are absent in the migratory DC fraction of MLN. Plots gated as 
in Figure S2 
(E) SFB levels on Day 12 assessed by Q-PCR for SFB 16S rRNA gene normalized to 





Figure 3-S6. CCR2 expression on lamina propria MNP subsets 
(A) CCR2+ cells in small intestinal LP MNP subsets from WT and CCR2-DTR mice 
treated with DT for 12 days. Plots gated on MNP subsets as outlined in Figure S1.  
(B) WT C57BL/6 mice were treated with a single injection of blocking anti-CSF1R 
antibody (AFS98) or isotype control (IgG). Small intestinal LP MNP subsets were 











Table 3-S1. MNP subsets in various mouse models used in this study 
Comparison of the size of individual MNP subsets in different mouse models. Total cell 
numbers in each fraction in the small intestinal lamina propria (x104). Main numbers 
represent mean (x104) and secondary numbers – standard deviation of the mean. 
Statistically significant differences from WT littermates are marked in red. Significance 











Intestinal T cell homeostasis is essential for achieving a balance between chronic 
intestinal inflammation and protective mucosal immune responses. How commensal 
microbes regulate T cell homeostasis and how this modulation affects immune responses 
to innocuous and pathogenic antigens remain poorly understood. It is well appreciated 
that distinct commensal species control specific effector T cell fates and modulate innate 
immune pathways. However, the nature of the innate immune cells that relay microbial 
information and the mechanisms by which they guide mucosal immune responses to 
commensals and pathogens are unclear.  
 Here, we examined in detail the mechanisms of Th17 cell induction by a 
commensal bacterium. We made significant progress towards understanding how SFB 
interact with innate immune cells to regulate local immune responses. We showed that 
cytokine environment is not sufficient to drive SFB-specific Th17 cell differentiation. 
However, the response to this microbe is antigen-specific and we find that most SFB-
induced Th17 cells recognize and respond to SFB antigens. We also investigated the role 
of various intestinal APCs in this response. We queried all known intestinal lineages that 
possess antigen presentation capabilities and identified CD11c+ cells as necessary and 
sufficient players in this process. We also identified intestinal Mfs as essential for 
induction of the SFB-specific Th17 cell response. During the course of this work, we 
came to appreciate the diverse ontogeny of LP MNPs. Accumulating evidence proposes a 
division of labor among LP MNPs to explain how immune subsets decode innocuous and 
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pathogenic stimuli, mount proper immune responses and prevent overt 
inflammation61,64,67,87,199,229,236,240,319,320. However, studies supporting such roles in vivo 
are lacking. To understand how SFB modulate the host adaptive immune system, I set on 
to examine the contribution of the various LP MNPs to SFB-specific Th17 cell 
differentiation. This work represents one of the first systematic investigations of the role 
of individual intestinal MNP subsets in control of intestinal immune homeostasis in vivo.  
One of the main findings from this work is that intestinal macrophages are 
essential for induction of SFB-specific Th17 cell differentiation. This is in contrast to 
previous reports that define DP DCs as the DC subset responsible for Th17 cell 
differentiation61,64,234,237. Instead, we find that SI DP DCs are dispensable for generation 
of SFB-specific CD4 T cells. Indeed, in the absence of these cells from LP and MLNs in 
Langerin-DTA mice, SFB-specific Th17 cell differentiation progresses similarly to 
control mice. To exclude the possibility of redundancy among pre-DC derived DCs, we 
also examined SFB-specific Th17 cell induction in Langerin-DTA/BATF3-/- and Flt3L-/- 
mice, which lack all CD103+ DCs and over 95% of classical DCs, respectively. 
Strikingly, SFB can still mediate Th17 cell differentiation in these models, reinforcing 
our observation that priming of SFB-specific T cells and Th17 cell induction is not reliant 
on conventional migratory LP DC subsets. Furthermore, our results show that DP DCs 
are not sufficient for Th17 cell induction by SFB because SFB-specific CD4 T cells are 
not generated in DT-treated CCR2-DTR mice, in which DP DCs are the only remaining 
DC subset. 
What is the actual function of classical DCs and CD64 Mfs in SFB-specific 
Th17 cell differentiation? CD64 Mfs have been shown to acquire and process antigens 
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for presentation228,230,236, release Th17-cell inducing cytokines177,200,277, and support 
immunoprotective functions during infection with extracellular bacteria75. They can also 
migrate to MLNs under certain conditions236. It is therefore possible that CD64 Mfs are 
the sole drivers of SFB-specific Th17 cell differentiation. Tissue-resident CD64 Mfs are 
insensitive to TLR stimulation and are classically viewed as anti-inflammatory due to 
high secretion of cytokines such as IL-10. Indeed we confirmed Il-10 expression from 
CD64 Mfs and not LP DCs (unpublished data). However, in the context of infection or 
acute inflammation in the colon, Ly6chi monocytes can give rise to proinflammatory 
CX3CR1int Mfs with enhanced migratory and antigen presentation abilities without 
altering the fate of the residual anti-inflammatory Mfs31,321. Thus, CD64 Mfs derived 
from the same progenitors are capable of assuming different fates depending on the 
context and location of macrophage maturation and function. However, the CD64 Mfs 
examined in our study do not resemble pro-inflammatory Mfs. CD64 Mfs express MHCII 
and similar levels of costimulatory molecules CD40, CD80, and CD86 to those of 
conventional LP DCs52 suggesting that at least phenotypically they are functional antigen 
presenters. In addition, ex vivo assays with sorted SI LP CD64 Mfs and transgenic CD4 T 
cells demonstrate that they can induce T cell proliferation, albeit less efficiently than 
classical CD103 SP DCs or DP DCs (51,64, and our own data). Previous studies show that 
addition of GM-CSF alone to bone-marrow derived monocytes in vitro can drive 
expansion and differentiation of monocytes into cells with antigen presentation capability 
322. While GM-CSF deficiency does not impair development of LP CD64 Mfs51, these 
cells are responsive to GM-CSF released by ILC3 cells in response to microbial 
signals277. Thus, microbiota-mediated GM-CSF production may facilitate LP macrophage 
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maturation and antigen presentation. Whether SFB stimulate GM-CSF production from 
ILC3 cells or other innate immune cells has not been examined. Despite the lack of this 
knowledge, SFB have been recently proposed to facilitate a crosstalk between CD64 Mfs 
and ILC3 cells to promote local differentiation of SFB-specific Th17 cells 253. 
CD64 Mfs express low levels of CCR7 and are present at low numbers in the 
MLNs at steady state 51,64,77, however, they can upregulate CCR7 and migrate to the 
lymph when exposed to non-invasive Salmonella typhimurium in antibiotic-treated 
animals 236. At steady state, SFB are the sole epithelium-associated commensal species in 
laboratory SPF mice (unpublished data from our lab). Therefore, we hypothesize that 
innate immune sensing of this abundant species in conjunction with their direct contact 
with host IECs encourage SI CD64 Mfs to function as APCs 200,323. As mentioned above, 
several reports suggest that innate immune recognition of SFB by SI CD64 Mfs must take 
place as these cells produce high IL-1β in mice colonized with SFB, although the exact 
signaling pathways are still debated 177,200. We, however, notice that CD64 Mfs produce 
similar levels of IL-1β before and after five days of SFB colonization, although we 
cannot exclude the possibility that more IL-1β is produced earlier on (unpublished data).  
Of note, during C. rodentium infection de novo differentiated intestinal macrophages 
release IL-1β by activating the non-canonical caspase-11 inflammasome, thus providing 
evidence for IL-1β secretion through a MyD88-independent innate pathway 68. Whether 
the same inflammasome pathway recognizes SFB remains to be explored. As both C. 
rodentium and SFB attach strongly to IECs and induce Th17 cell differentiation200, it is 
plausible that both species undergo similar innate sensing, albeit with different final 
outcome (i.e. homeostasis versus immunoprotection).      
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CD64 Mfs may also be required for SFB-specific Th17 cell differentiation by 
communicating with and instructing local conventional DCs to prime CD4 T cells. In 
light of this possibility, all of the models we employed still carry CD11b SP DCs at 
varying levels. While these cells have been shown to migrate to lymph and prime effector 
T cells 61,66,78, we do not know if they perform similar functions in SFB colonized mice. 
Furthermore, as mentioned above, the origin of these cells is unclear as they seem to be 
highly heterogeneous 55,34,56,70. CD11b SP DCs are thought to derive from Flt3L-
dependent precursors66, but are not outcompeted in WT:Flt3L-/-  competitive BM 
chimeras56. IRF4 deficiency in CD11c+ cells impairs migration of CCR2+CD103- DCs to 
the MLNs, but CD11b SP DCs are only reduced by 50% in these mice61,66. These CCR2-
expressing CD11b SP DCs seem to rely on CCR2 for entry into LP, but paradoxically, do 
not seem to develop from CCR2-expressing monocytes66.  We find that CD11b SP DCs, 
including the CCR2+ subset, are significantly reduced in Flt3L-/- LP and MLNs, but not 
completely ablated, suggesting that some subpopulations of these DCs rely on Flt3 
signaling. As mentioned earlier, Flt3L-/- mice show normal induction and numbers of 
SFB-specific Th17 cell cells so we can exclude a role for Flt3L-dependent CD11b SP 
DCs in this process. Similarly to Scott et al, we find that transfer of exogenous CCR2-
expressing monocytes does not recover the CCR2+ CD11b SP DCs, or any CD11b SP 
DCs for that matter, in either LP or GALT, which underscores that their origin is distinct 
from that of CD64 Mfs. However, we have noticed an increase in endogenous CD11b SP 
DCs in both SI LP and MLNs in some of the mice with transferred WT monocytes. These 
results suggest that the remaining LP DCs in Flt3L-/- may be a mixture of non-classical 
APCs such as monocyte-derived DCs, monocyte-macrophage intermediates 324 and even 
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atypical MHCII-expressing eosinophils 325, which may rely on various extrinsic factors 
for development and survival (i.e. GM-CSF, M-CSF, IL-34, IL-3, IL-4). Our results 
cannot completely exclude a role for these cells in generation of SFB responses. 
 Despite that nearly all CD11b SP DCs are CX3CR1-GFPint, they also express 
classical DC markers such as CD24, CD26, Zbtb46 and are reduced in Flt3L-/- LP 
stressing that CX3CR1 expression cannot be used on its own to indicate monocyte origin 
or commitment to macrophage fate. Of note, CD11bhi population that is Notch2-
independent and expresses high levels of CX3CR1 and Flt3 and variable levels of CD4 
has been reported86, which was suggested to represent nonlymphoid F4/80-expressing DP 
DCs56. However, CD11b SP DCs may also easily be the equivalent of this lymphoid 
CD11bhi population. Intriguingly, DC-specific ablation of IRF8 leads to increased 
proportions of CD11b SP DCs in the LP and significant increase in levels of CD11b SP 
DCs within the migratory MLN DCs, suggesting that IRF8 negatively regulates 
development or migration of CD11b SP DCs93. Supporting this, we observed increased 
levels of CD11b SP DCs in BATF3-/- mice (unpublished data). It will be important to 
identify transcriptional signatures of CD11b SP DCs to better define this subset 
developmentally, develop strategies for targeting them genetically and identify SFB-
driven transcriptional changes.      
Depletion of intestinal Mfs in DT-treated CCR2-DTR led not only to lack of Th17 
cell induction by SFB, but also to lack of SFB-specific CD4 T cells in LP. We, 
therefore, hypothesize that CD64 Mfs are required for acquisition of SFB antigens. 
The exact mechanism(s) by which CD64 Mfs take up SFB antigens (i.e. transepithelial 
dendrite-mediated luminal sampling, transfer from IECs, engulfment of apoptotic IECs) 
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will need to be characterized in the future. SFB adhesion to IECs is required for Th17 cell 
induction and possibly for induction of SFB-specific T cells200. Thus, SFB are uniquely 
positioned for sampling by CD64 Mfs. This mechanism may be common for epithelium-
associated bacteria.     
 A major unanswered question is the role of CD64 Mfs beyond antigen 
acquisition. They may serve as actual antigen-presenting cells in priming SFB-specific 
CD4 T cells or transfer the antigens to LP DCs. CD64 Mfs may also participate in the 
Th17 cell differentiation stage by producing Th17 cell-inducing cytokines. Our results 
strongly suggest role of Mfs as APCs, however they were insufficient to prove such a 
role. We have planed the following experiments to address this possibility. To understand 
whether CD64 Mfs are necessary for antigen presentation, we propose to reconstitute the 
macrophage niche in DT-treated CCR2-DTR mice with MHCII-deficient macrophages. 
To this end, we would transfer Ly6chiCCR2+ monocytes from MHCII-/- mice into Mf-
deficient mice and ask whether the newly differentiated macrophages can induce SFB-
specific Th17 cell differentiation. Our preliminary transfers of MHCII-deficient 
monocytes were unsuccessful at fully reconstituting the macrophage niche. As an 
alternative, we are generating mice that lack MHCII on macrophages and monocytes 
(LysMΔMHCII) and we plan to assess SFB-specific Th17 cell differentiation before and 
after colonization with SFB. To address whether Mfs are sufficient for SFB-specific 
Th17 cell differentiation, we are also generating mice, which carry MHCII specifically on 
Mfs (MHCIILysM). Because these gain-of-function mice will not contain endogenous CD4 
T cells due to lack of selection on MHCII, we will transfer SFB Tg T cells and assess 
their proliferation and differentiation into Th17 cells. Another experiment that would test 
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the requirement of antigen presentation by Mfs is mixed CCR2-DTR:MHCII-/- BM 
chimera. Upon DT treatment these BM chimeras would carry only MHCII-deficient Mfs, 
whereas there would be an equal representation of MHCII-sufficient and deficient DCs. 
Our preliminary results revealed a caveat with this experiment because DT-treatment led 
to loss of both MHCII-sufficient Mfs and DCs. We presume that competition at the 
Mf/DC precursor stage after DT administration led to over-representation of MHCII-
deficient progenitors. More experiments are necessary to clarify the role of MHCII in 
development of macrophages. 
In order to gain information about which DC subset contains SFB antigens in vivo 
we isolated DP DCs and Mfs from SI LP and examined their ability to activate SFB Tg T 
cells without addition of exogenous antigen. The presumption was that only cells 
presenting endogenous SFB antigens will activate the Tg T cells. We observed that DP 
DCs, but not CD64 Mfs, can induce proliferation of SFB Tg T cells in the absence of 
exogenous antigens. We confirmed that isolation of these cells did not impair their ability 
to present exogenous antigens. Indeed, both isolated DP DCs and CD64 Mfs could 
activate SFB Tg T cells in the presence of exogenous antigen, albeit CD64 Mfs were half 
as efficient as DP DCs. These results may suggest that CD64 Mfs do not carry SFB 
antigens, however, alternate explanations are also likely. As CD64 Mfs are more 
phagocytic than DP DCs, it is possible that SFB antigens are either lost during the 
isolation process or degraded to levels below the detection threshold of this assay. In 
addition, the proportion of CD64 Mfs that carry SFB antigens may be low such that more 
Mfs are necessary in this assay. Of note, Th17 cell levels were observed at normal levels 
in mice lacking MHCII on DP DCs (Langerin-DTAΔMHCII, 113), suggesting that antigen 
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presentation by DP DCs is not essential. Using our assay we cannot exclude the 
possibility that CD103 SP DCs or CD11b SP DCs carry SFB antigens. We have not been 
able to isolate equivalent numbers of these populations compared to DP DCs. We also 
have yet to test whether these DC subsets carry SFB antigens in Langerin-DTA or 
Langerin-DTA, BATF3-/- mice. In addition, we do not know whether in the absence of 
DP DCs or all DCs, CD64 Mfs now carry SFB antigens for presentation to SFB Tg T 
cells.  
Thus, it is possible that CD64 Mfs transfer SFB antigens to DP DCs (or any DC 
subset) for presentation to SFB-specific CD4 T cells. DT-treated CCR2-DTR mice 
contain normal levels of DP DCs in LP and MLN but lack CD64 Mfs and lack SFB-
specific Th17 cells. In the antigen transfer scenario, DP DCs would not carry SFB 
antigens in DT-treated CCR2-DTR mice and therefore, not be able to induce activation of 
SFB-specific CD4 T cells. Conversely, in the absence of all DCs, in Flt3L-/- mice, CD64 
Mfs would be loaded with SFB antigens and may present the antigens themselves. As we 
have shown above, SFB can induce Th17 cell differentiation in the absence of GALT and 
MLN. Therefore, CD64 Mfs may induce activation and differentiation of SFB-specific 
Th17 cells within the LP.    
In addition, Mfs may participate as cytokine producing cells for induction of SFB-
specific Th17 cell differentiation. In this regard, we examined the production of Th17 cell 
cytokines by DP DCs and CD64 Mfs in the ileum of SFB colonized mice. We observed 
that CD64 Mfs generated higher levels of IL-6, IL-1β, and IL-23p19 than DP DCs, which 
suggests that CD64 Mfs preferentially induce Th17 cell lineage-skewing cytokines. 
Because of the contributions of IL-23, IL-1β and IL-6 to distinct stages of Th17 cell 
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differentiation, CD64 Mfs may be required for both initiating the Th17 lineage 
transcriptional program and for driving poised SFB-specific RORγt+ CD4 T cells to 
secrete Th17 cell-specific cytokines, and thus finally commit to the Th17 cell lineage. In 
this regard, SAA proteins were shown to condition the neighboring CD11c+ cells to 
produce IL-1β, which together with IL-6 and TGF-β enhance Th17 cell differentiation. 
Myeloid cell-derived IL-1β appears to act in a paracrine manner and enhance production 
of epithelial SAA, thus ensuring amplification of Th17 cell differentiation200.  
 In most of our Mo transfer experiments we noticed recovery of endogenous DCs 
in the MLNs and higher levels of SFB-specific Th17 cell differentiation. Therefore, 
another possibility is that CD64 Mfs do not present the antigens, but provide trophic 
factors to DCs to induce their maturation and enhance their role as antigen presenters. DP 
DCs and CD11b SP DCs may be especially receptive to these trophic factors due to their 
mixed origins. Macrophage-derived trophic signals have been shown to facilitate tissue 
development (i.e. ductal branching, bone morphogenesis, and generation of adipose 
tissue) and tumor invasion (i.e. angiogenesis, extracellular matrix manipulation) 326. GM-
CSF, G-CSF, M-CSF, Flt3L, TGFβ, and IL-1β are a few candidate factors that intestinal 
CD64 Mfs could elicit to support development of DC subsets, enhance their antigen 
presentation functions and promote production of specific cytokine milieus 327-329. 
Alternatively, Wnt/β-catenin pathways have been shown to maintain intestinal 
homeostasis, induce tolerogenic functions in dendritic cells and regulate inflammatory 
responses to pathogens 330-332. Other extrinsic factors such as chemokines and 
semaphorin-plexin systems influence DC viability, migration to lymph and induction of 
antigen-specific T cell responses 329,333. Overall, trophic factors provided by macrophages 
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could augment the efficiency of the LP MNP system and thus, regulate immune 
responses.  
 SFB colonization induces Th17 cell differentiation without altering the 
representation of the other effector T cell lineages, but it increases the ratio of Th17 cells 
to pTreg cells, since these two lineages are in a tightly regulated equilibrium with each 
other. Our unpublished observations confirm that SFB do not induce pTreg 
differentiation and that there is no difference in pTreg levels between WT or DC-
deficient mice before and after SFB colonization. We further confirm previous 
observations that BATF3-/- mice show no defect in FoxP3+pTreg proportions and that 
Flt3L-/- mice have reduced levels of FoxP3+pTregs. In contrast to Welty et al, we do not 
notice significant impairment of FoxP3+pTregs in Langerin-DTA, BATF3-/- mice, which 
suggests that pTreg differentiation can occur in the absence of all CD103+ LP DCs. 
Because of the pTreg defect in Flt3L-/-, we propose that LP DCs act redundantly for 
induction of pTregs. Since induction of colonic pTregs seems to resemble that of SI Th17 
cells, it remains to be investigated whether individual or multiple colonic LP DCs are 
required for commensal-mediated pTreg differentiation.  
 With respect to the non-SFB microbiota, we find that LP MNP subset-specific 
deficiencies do not reduce further the few numbers of Th17 cells observed in mice 
lacking SFB. This observation suggests that either LP MNPs act redundantly to induce 
Th17 cell differentiation in response to luminal commensals or that other innate immune 
cells are necessary altogether for this process. It will be interesting to determine whether 
there is a specific luminal commensal species that induces the residual Th17 cell 
differentiation or whether it is a joined effort of the microbial community. If specific 
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species are identified, it will be important to compare and contrast their mechanisms of 
induction of Th17 cell differentiation to those of mucosa-attaching SFB. Genetic 
manipulation of both the luminal species and SFB will prove useful for generating 
targeted therapies for inflammatory bowel diseases. 
 In this thesis study, we have shown that among LP CD11c+MHCII+ subsets, 
CD64 Mfs are necessary for induction of SFB-specific Th17 cell differentiation. Their 
precise contribution to this immune response remains to be explored, but our data points 
to collaboration with conventional LP DCs. Specifically, our data suggests that SFB 
antigen acquisition, antigen processing, and induction of Th17 lineage-skewing cytokine 
milieu are supported by LP Mfs, while SFB antigen presentation and activation of SFB-
specific CD4 T cells are facilitated by conventional LP DCs. In addition, in the absence 
of LP DCs, CD64 Mfs can perform all of these functions. Our studies focus on de novo 
induction of Th17 cell differentiation so we do not know which LP MNP subset plays a 
role in maintenance of SFB-specific Th17 cell responses or in development of SFB-
specific memory Th17 cells, if these cells exist. Upon depletion of CD64 Mfs after SFB-
specific Th17 cell differentiation occurred, we found that Th17 cell levels were not 
reduced showing that CD64 Mfs are not necessary for maintenance of Th17 cells. It is 
possible that once SFB-specific Th17 cells are induced they can be maintained either by 
any LP MNP subset or by autocrine/paracrine cytokine signaling. Of course, the latter 
possibility excludes the need for constant SFB antigen presentation and suggests that 
SFB-specific Th17 cells are stable and committed to their fate. In this regard, it will be 
important to remove SFB after Th17 cell differentiation occurred and assess any changes 
in Th17 cell levels over time. As mentioned earlier, adhesion to IECs is postulated to be 
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required for Th17 cell differentiation and it is a feature of both commensal SFB and 
pathogenic bacteria and fungi such as Citrobacter rodentium and Candida albicans. 
Because CD64 Mfs play an important role in SFB-specific Th17 cell differentiation, it is 
worth exploring whether they are necessary for Th17 cell differentiation driven by all 
epithelium-associated microbes. 
 Our work helps elucidate the mechanisms of induction of commensal-specific 
mucosal T cell responses. Similarly to previous knowledge that colonic pTregs consist of 
commensal-specific TCRs, we showed that small intestinal SFB-induced Th17 cells 
consist mostly of SFB-specific TCRs. In addition, we propose that SFB-specific Th17 
cells are primed and differentiate locally in the LP, which has also been suggested for 
commensal-specific but not food antigen-specific pTregs. We then show that LP MNPs 
present SFB antigens for induction of SFB-specific Th17 cell differentiation, and we find 
that CD64 Mfs are especially important in this process. The precise roles that CD64 Mfs 
play in SFB-specific Th17 cell induction have yet to be described. Furthermore, whether 
CD64 Mfs play a role in commensal-specific pTregs has also not been explored. 
Nevertheless, our work is the first to propose an MNP subset that is required for 
induction of a commensal-specific mucosal T cell response. Looking forward, it is worth 
exploring the interplay among different MNP subsets that leads to induction and 
discrimination of commensal-specific from pathogen-specific T cell responses. It is 
further important to understand whether differentiation of commensal-specific T cells can 
be subverted to induce pathogenic mucosal T cell responses. Our knowledge of the 
distinguishing features of commensal-specific versus pathogen-specific T cell response 
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